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SUMMARY 
Balloon dilatation of the stenosed mitral valve, in an attempt to relieve symptoms, was 
developed to replace the surgical procedure of closed mitral valvotomy. This procedure, 
whereby a balloon tipped catheter is introduced from the femoral vein and directed across the 
mitral valve after an atrial septal puncture, was developed in 1982. The procedure was first 
performed at Groote Schuur Hospital in 1988. Two types of dilating balloon (Inoue and 
Bifoil types) have been used. 
The aim of this retrospective study was to analyze the results of balloon mitral valvuloplasty 
procedures performed from 1988 until November 1992. In addition a detailed analysis was 
made of all complications of the procedure. 
118 patients (mean age 30. 7 years) underwent 124 attempted procedures. 93 % of attempts 
were successfully completed and an optimal result was achieved in 76% of patients. Mitral 
valve area increased from 0.9cm2 to 2.0 cm2 • Equivalent results have been achieved with 
both balloon types. 
Death occurred in 1. 6 % of patients. 2 .4 % of patients had severe mitral regurgitation as a 
complication. 4% of procedures resulted in cardiac chamber perforation. 
The experience at Groote Schuur has been similar to other centres treating young patients 
with rheumatic mitral stenosis. 
V 
TABLE OF CONTENTS 
Declaration page m 
Acknowledgements page 1v 
Summary page v 
CHAPTER 1 
Introduction page 1 
Mitral Stenosis-Etiology and Natural History page 1 
The Surgical Treatment of Mitral Stenosis page 6 
References-Chapter 1 page 18 
CHAPTER 2 
The History of Balloon Valvuloplasty page 23 
References-Chapter 2 page 25 
CHAPTER 3 
Methods of Balloon Mitral Valvuloplasty page 27 
The Bifoil and Trefoil Technique page 29 
The Inoue Technique page 31 
Vl 
References-Chapter 3 page 37 
CHAPTER 4 
The Selection of Patients for Valvuloplasty page 39 
The Role of Echocardiography in Patient Selection page 42 
References-Chapter 4 page 47 
CHAPTER 5 
The Pathological Consequences of Balloon Valvuloplasty page 51 
References-Chapter 5 page 53 
CHAPTER 6 
Complications page 54 
References-Chapter 6 page 61 
CHAPTER 7 
Results of Balloon Valvuloplasty page 64 
References-Chapter 7 page 76 
Vll 
CHAPTER 8 
The Results of Percutaneous Balloon Valvuloplasty 
at Groote Schuur Hospital 
Section A: Methods, Definitions and Procedures 
Section B: Base-Line Characteristics 
Section C: The Outcome of Balloon Valvuloplasty 
Section D: The Complications of Balloon Valvuloplasty 
Section E: Symptomatic Improvement and Follow-Up 
References-Chapter 8 
CHAPTER 9 
Discussion 
References-Chapter 9 
Vlll 
page 80 
page 80 
page 82 
page 89 
page 95 
page 100 
page 102 
page 103 
page 108 
1 
CHAPTER 1 
INTRODUCTION 
A significant aspect of recent cardiological research has been the development of techniques 
which can eliminate the need for a thoracotomy and general anaesthesia (as well as cardio -
pulmonary bypass) and achieve comparable results to standard surgical procedures. Despite 
the absence of a controlled study comparing medical and surgical therapy, the surgical 
treatment of patients with significant mitral stenosis is felt to be superior to medical therapy 
and to offer patients relief from symptoms at least if not a survival advantage. Balloon 
dilatation of the stenosed mitral valve has been developed to replace surgery. Short-term 
results suggest that balloon valvotomy is a good alternative to surgical valvotomy. It has not 
yet been established whether this will be true in the long-term. 
Balloon mitral valvotomy has been performed at Groote Schuur hospital since 1988. Prior to 
presenting the results of balloon valvotomy at Groote Schuur Hospital, I will attempt to 
review the published literature relating to the technique in order to place the local results in 
perspective. 
MITRAL STENOSIS - ETIOLOGY AND NATURAL HISTORY 
Mitral stenosis in the adult is usually the result of rheumatic fever and the mitral valve is 
most commonly involved by the rheumatic process. 1 
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Only 50% of patients with mitral stenosis will have a history of rheumatic fever despite 
having typical pathological features consistent with a rheumatic process when pathological 
material is examined. 2 In the classical review of the subject of mitral stenosis Paul Wood 
found that progression to a stage of symptoms equivalent to Class IV of the New York Heart 
Association (NYHA) grading takes 7 to 10 years from onset of symptoms. 3 The average age 
of onset of Wood's patients was 12 years of age. Symptoms developed at an average age of 
31 years. In a series of 1000 patients started by Duckett Jones in 1928 the average age of 
onset of rheumatic fever was 8 years. 4 (This average is in a sense artificial in that patients 
older than 20 years were left out of the series). 4 
In the series of Bland and Jones of the 117 patients who had clinical mitral stenosis at 20 
years of follow-up, only 40 (34 % ) had evidence of mitral stenosis at 10 years of follow-up. 
The time taken for the development of symptomatic mitral stenosis following an attack of 
rheumatic fever in other areas of the world, particularly the so called 'Third World', is felt 
to be shorter. 5 
The progression of stenosis may relate to repeated attacks of rheumatic fever, or an ongoing 
inflammatory reaction, 6 or to the effect of turbulence causing repetitive minor trauma to the 
narrowed mitral orifice with progression of stenosis being as a result of fibrosis. 7 There does 
not appear to be hard evidence for the last claim other than by comparison to the natural 
history of bicuspid aortic stenosis. The progression of disease clearly varies in patients with 
varying levels of symptomatology. This is illustrated in Rowe's series and in a paper from 
Selzer' s group. 8•9 40 % of patients with clinical mitral stenosis but no symptoms on 
presentation survived 20 years. Half of these patients remained asymptomatic. 8 This slow 
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progression of mitral stenosis in patients who have minor symptoms can be seen as a counter 
to those who favour early dilatation of the clinically stenosed mitral valve by whatever means. 
The variable progression to the development of symptomatic mitral stenosis is reflected in the 
marked differences in the mean age of populations currently undergoing balloon valvotomy 
in different parts of the world. Chen et al reported a series from mainland China with a mean 
age of 33.8 +/- 7.6 years. 10 A typical United States based study has a mean age of 53 +/-
15 years. 11 
In a review in Circulation in 1972 Selzer and Cohn summarized '(t)he pathologic evolution 
of mitral stenosis'. 8 They described the progression of rheumatic involvement of the valve 
from the nodules consisting of fibroblasts and macrophages which are found along the 
opposing edges of the valve and which characterise acute valvulitis to the thickening and 
fibrosis of the valve which results in alteration of the underlying structure of the valve. These 
structures then are also subject to calcification. The valve cusps become fused together as do 
the subvalve structures. Rusted, Scheifley and Edwards, in a pathological study, listed three 
main types of mitral stenosis depending on the parts of the valve structure involved. 12 They 
described a commissural type in which the fusion of commissures predominates, a cuspal type 
in which the leaflets are stiffened and inflexible and a chordal type. In the latter type the 
chordae become fused. They define these as pure forms and feel that combinations of the pure 
forms occur. 
Sellors and co-workers developed a grading system of stenosis based on pathological findings 
at operation. 13 The Sell ors grading is reflected in the contemporary echocardiographic scoring 
system. In their system Sellors et al defined three types of val var abnormality: (a) the mobile 
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cusps without subvalve changes - diaphragmatic type; (b) thickened cusps with mild to 
moderate subvalvar abnormality; and (c) rigid cusps with severe subvalvar change - the funnel 
type. They recognised that the patients with mobile valves had the best results at surgery. 
The clinical findings noted in patients with mitral stenosis are well documented1 and I will not 
deal with them specifically. The patient with NYHA class IV symptoms usually has a valve 
area of 1 cm2 or less. (The normal mitral valve area is between 4 and 6cm2). 1 At this stage 
the pressure in the left atrium is approximately 25mm Hg while the left ventricular end 
diastolic pressure is normal. 14 The cardiac index at this time may have fallen to 2.5 l.min-1.m-2 
from 3 l. min-1• m-2 • 14 The increased left atrial pressure is associated with an increase in 
pulmonary vein pressure and an increase in pulmonary capillary pressure. Pulmonary oedema 
is said to occur when plasma oncotic pressure is exceeded by pulmonary capillary pressure 
(25mm Hg). 14 Reactive changes in the pulmonary vascular bed are thought to develop at a left 
atrial pressure beyond 25mm Hg. Reactive changes in pulmonary pressure do not occur in 
all patients. Theoretical explanations consider pulmonary vasoconstriction to be responsible 
for this change. No author has been able to explain why pulmonary hypertension is present 
only in a percentage of patients with severe mitral stenosis. 15 The elevation in pulmonary 
pressures and consequent elevation of right ventricular pressures are responsible for the 
ultimate development of signs consistent with right sided failure. Patients with mitral stenosis 
and pulmonary hypertension are likely to be NYHA class IV limited. 15 
The pressure gradient between left atrium and left ventricle (the transmitral gradient) 
increases with any increase in flow across the valve - therefore an increase in heart rate will 
increase the flow across the mitral valve and left atrial pressure will increase. (Transvalvular 
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gradient is a function of the square of the transvalvular flow rate). 16 The symptoms of patients 
with mitral stenosis are thus worsened if they develop a tachycardia or if they develop atrial 
fibrillation with a rapid ventricular response. Furthermore loss of atrial contraction associated 
with the development of atrial fibrillation may decrease cardiac output by 20% .17 (The rapid 
ventricular rate associated with uncontrolled atrial fibrillation probably has a far more 
important role in the production of symptoms). 
There is no documented natural history of untreated mitral stenosis. Kirklin refers to the 
documented series of patients from the 1950's and 1960's as 'the spectrum of mitral stenosis 
in surgically untreated patients receiving the medical treatment that was available in the mid-
portion of the twentieth century'. 18 The survival of such patients is seen to relate to the 
clinical stage at which they were first seen and to the presence or absence of atrial 
fibrillation. 
Rowe and others documented a 84 % survival over 10 years in patients without symptoms 
when first seen. 8 A large series of patients documented by Olesen 19 showed that patients with 
NYHA Class IV equivalent symptoms as a result of mitral stenosis had a 0% 10 year survival 
rate (15% 5 year survival), compared to a 33% 10 year survival rate (62% at 5 years) in 
patients in NYHA functional class III. (Rowe's group with NYHA class III symptoms had 
a 15 % 10 year survival). 8 The group as a whole had a mean survival of between 6 and 7 
years from first consultation. Olesen' s large natural history series although widely quoted 
suffers from its vintage in that 14% of the patients were felt to have significant mitral 
regurgitation. (It even includes 12 patients who underwent mitral valvotomy - who were felt 
not to materially alter the series). In addition no patients were asymptomatic. Atrial 
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fibrillation was associated with a 0% survival at 20 years versus 29 % in patients in sinus 
rhythm. 19 Modern statistical techniques may have shown that the apparently worse outcome 
in patients with atrial fibrillation may not be true. Rowe's series showed little difference in 
outcome between patients with atrial fibrillation and those without. 8 Rowe's group as a whole 
had a higher percentage of survivors at 10 years (61 % versus 35 % ) because of the inclusion 
of the asymptomatic patients. At 20 years 79% of Rowe's patients were dead as opposed to 
83% of Olesen's. 
Patients with medically treated stenosis eventually develop irreversible pulmonary 
hypertension and right heart failure with cardiac cachexia being the final stage of the disease. 
Atrial fibrillation, secondary to raised atrial pressure and subsequent atrial dilatation is 
initially paroxysmal and then becomes permanent in 40 to 50% of patients. 20 Atrial fibrillation 
and associated atrial enlargement form the 'breeding ground' for potential emboli. These 
systemic emboli are often fatal. 15 
THE SURGICAL TREATMENT OF MITRAL STENOSIS 
Just as medical therapy has probably altered the natural history of patients with mitral stenosis 
from that of patients in the earlier part of the century where death closely followed the onset 
of symptoms, so surgical therapy has altered the natural history to allow the development of 
significant aortic and tricuspid valve disease. 18 
As a result of refinements developed during the late 1940' s the technique of splitting the fused 
mitral commissures of a beating heart entered the armamentarium of the surgeon. In 1923 
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E.C. Cutler and S.A. Levine had reported on mitral commissurotomy performed from the 
ventricular apex. H.S. Souttar reported on the opening of a stenotic mitral valve from the 
left atrium in 1925. Apart from Souttar's single patient, the initial results were poor. 18 
Baker, Brock and Campbell reported 6 survivors out of 8 in 1950. Their technique involved 
splitting the fused commissures with a specially developed knife or by simply using a finger. 21 
After these initial reports mitral valve surgery was attempted in many centres. The initial 
experience of mitral valvotomy at Groote Schuur Hospital was reported in 1955 when Schrire 
and co-workers detailed their experience with 75 patients. 22 
The Tubb's dilator was introduced in the late 1950's and allowed better control of splitting 
of the commissures with a dilator introduced from the apex of the ventricle. 23 The 
development of cardiopulmonary bypass techniques in the early 1960's allowed the surgeon 
to split the commissures under direct vision. In addition, if the valve was deemed to be 
unsuitable for simple commissurotomy it could be replaced with a mechanical prosthesis. 18 
(Mechanical prostheses began to be developed at this time). The chances of a clot being 
dislodged from the atrium and resulting in an embolus are also decreased. 
Apart fom embolisation the maJor complication of the technique is the production of 
significant mitral regurgitation which may lead to the need for valve replacement. This 
resulted in open techniques becoming more popular. 18 
The published series of closed mitral valvotomy are substantially larger than the series of 
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open valvotomy patients. Three series involving survival data on more than five hundred 
patients have been documented. The largest series is that of John et al from India. 24 They 
documented the course of 3724 patients with a mean age of approximately 27 years. The early 
post operative mortality in this series was 3.8%. The authors were able to obtain follow-up 
data on 70 % of the patients. (This was an outstanding effort considering that their patients 
came from all over the Indian subcontinent!) There was an actuarial survival of approximately 
85% at 24 years after operation. 78.3% had survived without the need for reoperation. The 
incidence of post operative mitral regurgitation was low - 0.3 % had severe regurgitation. 
Interestingly, in this series the patients in NYHA Class IV had a 4.2 % mortality which is 
relatively low. 
In a series of patients from South Africa, Commerford and co-authors reported their 
experience in 680 patients. 25 Actuarial survival was 78 % at 12 years post operation. 47% had 
not required reoperation. Operative mortality was just below 3 % . Like the series from India 
the patients were younger than a comparable group from the USA (mean age 33 years). In 
this series operative mortality for patients in NYHA Class II was 0% while it was 
approximately 12 % for those patients in Class IV. 
The major study of closed mitral valvotomy from the United States is that of Ellis et al who 
reported prolonged follow-up in 1000 patients. 26 This study documents an earlier time period 
than John's and Commerford' s since the patients began to be collected from 1949 - shortly 
after the introduction of the technique. Operative mortality in this series of patients was 3.3 % 
in their group III patients and 24% in their group IV patients. (Groupings are approximately 
equivalent to New York Heart Association class). This series states its incidence of 
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reoperation and mortality in terms of the 15 year follow-up for all patients. The incidence of 
reoperation for patients in group III is 33 % . Mortality data are difficult to compare since the 
15 year mortality figures do not include those patients who had another operation. 
A smaller but more recently documented study from the Mayo clinic details the long term 
survival of patients who underwent closed mitral valvotomy in the early 1960's. 57% of 
patients were alive without a second operation at 10 years post surgery. (79% of the total 
group of 207 patients were alive at 10 years and 55 % at 20 years post surgery). At 10 years 
post operation 90% were free of any embolic complication. 27 In this retrospective report the 
authors divide the patients into two groups on the basis of left atrial thrombus and valve 
calcification. (These are two features which they feel currently tend to preclude the 
performance of balloon valvotomy). Survival in the group without either characteristic was 
significantly better at 10 years post operation (84 % versus 70. 3 % ). 
Feigenbaum and others documented the haemodynamic changes after closed commissurotomy 
in 35 patients prior to a closed procedure and repeated the investigations 6 to 36 months post 
procedure. 28 Valve area increased from 1.3 ± 0.3 to 2.6 ± 1.0 cm2 • (Interestingly, the 
empiric constant used in calculation of valve area by the Gorlin formula was 31 instead of 
37. 7 used currently29 and this would mean that valve areas were slightly overestimated). Left 
atrial pressure declined from 20 ± 8 to 12 ± 4mm Hg. Pulmonary artery pressure dropped 
from 31 ± 11 to 21 ± 7mm Hg. 
A common theme to many reports is the attempt to identify factors present prior to surgery 
and at operation which may be used to predict survival without the need for repeat surgery 
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as well as overall long-term mortality. More recent series have used current methods of 
multivariate analysis to define such factors. As mentioned above preoperative NYHA class 
predicts outcome. Some series report demographic factors such as older age, female gender 
and Black race as being predictive of a worse outcome. 30,31 In other series such as that of 
Commerford these factors do not predict an adverse outcome. (This is presumably because 
of fundamental differences in the make-up of the population undergoing surgery). 25 
Commerford et al reported that the 'suitability' of the valve as determined by the surgeon at 
operation predicted the results of the procedure. For example, patients with 'good' valves had 
a survival of just over 50% versus a cumulative survival of slightly more than 20% in patients 
with 'bad' valves. Clinical assessment of mobility could also be used to predict a successful 
result. In the series of Ellis et al val var calcification (in a sense partially equivalent to a 'bad' 
valve) at operation contributed to a poorer outcome with time. 26 
The presence of pulmonary hypertension preoperatively is possibly a predictor of a poor 
outcome. Hickey et al (see below) concluded that a raised pulmonary vascular resistance 
preoperatively was associated with a decreased long-term survival. 30 In a series from 
Denmark, Ravkilde and Hansen demonstrated that a mean capillary wedge pressure greater 
than 25mm Hg rather than pulmonary pressure was an independent risk factor for poor 
survival extending out to 34 years. 31 Hickey determined that mitral regurgitation immediately 
after the procedure was also a risk factor for a poor long-term outlook. 30 Repeat valvotomy, 
while associated with a slightly higher operative mortality is not associated with a poorer 
outcome. 25 
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It has been claimed that open mitral valvotomy is better than the closed technique. Apart from 
the 'visibility' and ability to avoid embolus propagation the technique is said to provide better 
results in terms of valve area. 
The favourable light in which many surgeons view open valvotomy is probably as a result 
of its use during a period when there were few imaging modalities available to predict val var 
morphology prior to surgery. For the reader of published series differences in statistical 
techniques used to assess survival and differences in selection of patients render easy 
comparison difficult. Furthermore, careful reading of papers is often required to determine 
how many patients underwent mitral valvotomy alone - in other words, without other 
procedures such as coronary bypass grafting). 
Aaron and Lower summarized their perceived advantages of the open technique in an article 
in 1974.32 According to these authors the technique offered the following: 
1. The valve could be viewed in a dry field. 
2. Clot in the left atrium can be seen and removed reducing embolisation. 
3. Easy assessment of valve competence can be made and the valve can be 
replaced if necessary. 
4. Clinical entities masquerading as mitral stenosis such as myxoma can be dealt 
with readily. (Irrelevant in the 'echo' era.) 
5. Other valve lesions can be dealt with at the same sitting. 
6. Trainee surgeons can easily be trained to perfect techniques m an easily 
viewed field. 
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The operative mortality (older authors use the hospital mortality while more recent authors 
use 30 day mortality) for open valvotomy ranges from O to 10. 8 percent. 30•33 •34•35 •36•37 •38 •39 
In these series reporting results in numbers of patients ranging from 95 to 347 patients, it is 
difficult to determine how the operation was selected. In one series of patients with what 
appears to have been simple mitral stenosis (reported by Laschinger et al) more than 50% 
underwent valve replacement. 39 Long-term survival analysis using actuarial techniques has 
been performed and while most authors report good long-term results in terms of mortality 
data on freedom from reoperation is not always stated. Nakano and co-authors report a 14 
year actuarial survival rate of 94.6 ± 0.02% with 83.8 ± 0.05% freedom from operation at 
14 years. 38 Laschinger reported an actuarial survival of 100% at 9 years post operation. 39 
Gross reported a survival of 92 % at 10 years. 37 In Housman's series the actuarial survival at 
10 years was 97 ± 2 % . However, the chance of not requiring a reoperation was 38 ± 16 % 
at 10 years. 36 The reasons for the differences in survival without reoperation between these 
two groups are not easily established. Housman's group dates from 1960 to 1975 and 
Nakano's dates from 1972 to 1985. Housman's group contains more patients in class III 
(NYHA). 
In a refreshing paper (because of its lucid descriptions of patient selection, operative technique 
and subsequent events) Cohn and co-authors described their experience with open mitral 
valvotomy. 40 In this series of 120 patients with a mean age of 49 years, the operative 
mortality was 0% and the actuarial probability of survival at 10 years was 95 ± 2 % . 
Freedom from reoperation at 10 years was 84 ± 5 % . 
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A number of series have documented the haemodynamic changes after open valvotomy. In 
Nakano's series in patients with pliable valves (Sellors type 1) the valve area increased from 
0.72 ± 0.08cm2 to 2.52 ± 0.19cm2 •38 In a series of younger patients from Iran, open mitral 
valvotomy was noted to result in a decrease in pulmonary wedge pressure from 28.8 ± 6.3 
to 13.8 ± 5.2mm Hg, whereas closed mitral valvotomy resulted in a decrease from 28.6 ± 
6. 2 to 17. 8 ± 7 .1 mm Hg. The numbers of patients are probably too small to offer an overall 
conclusion as to the superiority of one technique over the other. 5 
Analyses of open valvotomy series to obtain predictive outcome related variables have been 
reported. (These series are similar to the series discussed above concerning the closed 
procedure). 
In a senes from New Zealand, Smith et al reported that Maori race, preoperative 
symptomatology, preoperative mitral regurgitation, atrial fibrillation and pulmonary vascular 
resistance predicted a worse outcome. Valvular calcification and subvalvar deformity were 
operative predictors of a poorer outcome. 41 
Hickey et al state that the superiority of open versus closed techniques represents 
'conventional wisdom'. They state that this superiority has not been tested in a randomised 
controlled trial. By applying multivariate techniques to their own results (retrospectively) they 
concluded that after adjustments were made for preoperative risk factors 'all outcomes were 
the same after open and closed commissurotomy. '30 They reviewed all procedures performed 
between 1967 and 1988 at the University of Alabama. Median follow-up of the patients was 
11.4 years. Overall 10 year actuarial survival was 87%. After adjustment for risk factors 
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there was felt to be no difference between the techniques. 
In addition, Hickey et al criticise comparisons of closed mitral valvotomy to open mitral 
valvotomy for not having taken into account that at least some of the closed procedures were 
not performed with the aid of a Tubb' s dilator. 30 
It is worthwhile noting that reoperation post valvotomy is not always as a result of restenosis 
- failure of the first operation to improve the valve area and mitral regurgitation induced by 
the first operation are further reasons for repeat surgery. 15•42 Higgs noted in a series from 
1970 (post closed valvotomy) that only 11 % of patients with recurrent symptoms actually had 
restenosed. Early catheterisation had been performed in a series of 163 patients - 45 
subsequently returned with symptoms and were restudied. 36 % of these patients had persistent 
mitral stenosis with little change in valve area between their valve area at the time of 
symptoms and that immediately post commissurotomy. 42 In the large series of closed cases 
from India restenosis occurred at between 4.2 per 1000 patients at 5 years of follow-up and 
11.4 per 1000 at 15 years of follow-up. 24 (The method of diagnosis of restenosis is not 
stated). 
Dalen feels that no series of catheterisations post open mitral valvotomy has been performed 
and that the true incidence of restenosis has not been determined. 15 
Comparisons between open and closed valvotomy do not only involve considerations of 
mortality and reoperation but also consider differences in intraoperative and post operative 
emboli. The incidence of embolisation both preoperatively and post operatively depends on 
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the length of observation of the patient. 41 Furthermore, the occurrence of intraoperative 
emboli and the effects of these events are often ignored.41 It is difficult to compare the 
incidence of intraoperative and post operative embolisation (perioperative) in patients 
undergoing closed or open operations. In Ellis and Harken' s series the incidence was 6 % . 26 
In Housman's series (of open valvotomy) the incidence of early emboli was 2 % . 36 In the 
series from India of closed valvotomy the overall incidence of emboli in the early post 
operative period was approximately 1.2 % . 24 (This is calculated from the figures expressed in 
the paper which divide the patients according to sinus rhythm and atrial fibrillation). 
Long-term incidence of embolisation is also documented - in Laschinger' s series (post open 
valvotomy) the yearly incidence of post operative embolisation was 0.66%. 39 John et al 
reported an incidence of embolism of 0.4 % after closed valvotomy. 24 The interpretation of 
these data and their application to modern practice is difficult given that the practice of 
anticoagulation of patients in atrial fibrillation prior to surgery and after surgery varied. It is 
hard to imagine that post operative anticoagulation as practised in the United States was 
feasible on the Indian subcontinent. 
In Hickey's series the freedom from first post valvotomy thrombotic event was 90% at 10 
years and 82 % at 20 years. This is a combined value for both types of procedure. Previous 
embolism (pre-valvotomy) is a risk for embolism post operatively with freedom from a 
postoperative embolus in these patients of 61 % at 10 years and 38% at 20 years. 3° Cohn's 
series showed a 91 ± 3% freedom from emboli at 10 years post operation. Annual rates of 
thromboembolism expressed as percentage per patient year vary from 0.7 to 1.8% in patients 
who have had an open mitral valvotomy. 40 
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Because of the difficulties in comparing reported data and validating claims of improvement 
in incidence of embolisation after surgery it is felt that the ability of an operation alone to 
influence the occurrence of post operative emboli is doubtful. 43 Smith et al reviewed the 
problem of embolisation and came to a similar conclusion. 41 Partial protection from embolism 
also seems doubtful. 41 
The greatest weakness of all comparisons of closed and open valvotomy is that series are 
seldom presented with open valvotomy results on an 'intention to treat' basis. It is therefore 
difficult to distinguish which mitral valve replacements occurred because of a failed open 
valvotomy and which replacements occurred when the surgeon declared that the native valve 
was beyond repair on first inspection. 
Valve replacement has not assumed the position of primary treatment for uncomplicated mitral 
stenosis because even 30 years after development valve replacement remains an imperfect 
technique with a significant operative mortality. Despite relieving the pathology it creates a 
'neodisease' with the potential for embolisation, thrombosis and anticoagulant related 
bleeding. 44 
The risk of warfarin-related mortality is said to be 0.2 per 100 patient years (2.2 for 
morbidity) and the risk of a fatal thrombosis is 0.2 per 100 patient years (1 to 2 for 
morbidity). 1 
Bioprosthetic valves, which do not require the use of anticoagulants do not offer any benefit 
especially in a younger population as they are prone to degeneration. 44 
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No randomised prospective senes comparing elective mitral valve replacement to 
commissurotomy has been reported. In Laschinger's group of patients with mitral stenosis 
reported in 1982 who probably had 'too many' mitral valve replacements, the operative 
mortality was 11.2 % .39 Patients underwent Starr-Edwards prosthetic valve implantation. The 
group undergoing open mitral valvotomy had a 0% mortality. Actuarial survival at 9 years 
post valve replacement was 83. 9 ± 5.5 % (excluding operative deaths) versus 100% in 
patients after commissurotomy. 
The average operative mortality for valve replacement in the mitral position is said to be 
between 5 and 10%.45 A recent series has documented an operative mortality of 7.5% in a 
group of male patients undergoing mitral valve replacement with either a Bjork-Shiley 
mechanical valve or a Hancock tissue valve. 46 In this group operative mortality was 6.6% in 
those patients not needing additional bypass grafting. Interestingly, the mortality in patients 
less than 60 years of age was 3 % . Although the exact valvular pathology was not stated in 
the paper, it is safe to assume that the mitral valve lesions included severe calcification and 
significant regurgitation. No patient with ischaemic mitral regurgitation was included. 
The 11 year actuarial probability of survival with a prosthetic heart valve in the same group 
of patients was 58 % . 47 During the 1970' s the operative mortality for valve replacement in 
patients with mitral stenosis at Groote Schuur Hospital was 7% with a three year survival of 
approximately 84 % . 48 
Simple comparisons of survival data are difficult since the groups undergoing valve 
replacement represent a far more complex group as regards valve pathology, abnormal 
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ventricular function, coronary artery disease and associated illness than the patient with 
uncomplicated mitral stenosis. 
A report from Eguaras et al in 1990 compared two groups of (non-randomised) patients with 
mitral stenosis who either underwent valve replacement or open mitral commissurotomy 
depending on the degree of valve calcification.49 Although the groups of patients were 
relatively similar in terms of demographic description, there were slightly more patients with 
NYHA Class IV symptoms in the replacement group. The patient groups were relatively 
small - 60 patients with open repairs and 75 with valve replacements. The operative 
mortalities were not significantly different (4 % in the replacement group and 0% in the repair 
group) and the actuarial survival of the groups to 10 years did not differ significantly. 
Intriguingly, there was no difference in the probability of freedom from thromboembolism. 
The major difference related to freedom from reoperation. The patients undergoing valve 
replacement had a significantly higher actuarial probability of needing repeat surgery than the 
patients undergoing valve repair (69 ± 8.74% vs 84 ± 15.4%). In the valve replacement 
group, tissue valve degeneration contributed to the higher reoperation rate. 
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CHAPTER 2 
THE HISTORY OF BALLOON VALVULOPLASTY 
The conversion of techniques employed by cardiothoracic surgeons to their less invasive 
equivalents (which could be performed in the catheterisation laboratory) commenced during 
the 1960' s. Cheng has described William Rashkind' s development of balloon atrial septostomy 
as the birth of therapeutic balloon dilatation. 1 He considers the development of balloon 
angioplasty by Andreas Greuntzig to be another milestone in the history of balloon 
valvuloplasty since the technology relating to the development of flexible angioplasty catheters 
was applied when devices suitable to dilate stenotic heart valves were developed. 
Mitral stenosis (in a 33 year old man) was first treated with transvenous balloon dilatation on 
the 3rd of June 1982 by Kanji Inoue in Japan. 2 The device used was developed by Inoue 
himself and was used in 6 patients. (The device was introduced via a saphenous vein cutdown 
until changes in design facilitated the percutaneous introduction of the device). Ironically this 
balloon catheter had been developed for experimental atrial septostomy in dogs in 1980 as a 
potentially more effective device than the Rashkind balloon since it had the ability to create 
a larger orifice. This would have the theoretical advantage of avoiding the need for repeat 
septostomy or surgical septectomy in patients with transposition of the great arteries. 3 The 
device has been used in humans for this purpose as well. 1 
Lock et al reported the use of an alternative balloon (originally designed for peripheral vessel 
angioplasty) for valvuloplasty in 1985.4 This device was used in a group of 8 young patients 
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ranging from 9 to 23 years of age who came from India and the Azores. 
Al Zaibag and co-workers described balloon dilatation with two transvenous catheters in 
1986. 5 The reason for using two balloons appears to have been the concern that the larger 
diameter single balloon had a greater deflated profile and needed a larger hole in the atrial 
septum. Two smaller balloon catheters could be passed via two transeptal punctures. The 
resultant combined diameter of the two holes in the atrial septum would be less than the 
orifice needed for the single balloon. 5 In addition they were concerned that a single balloon 
totally occluded the mitral orifice. Furthermore, it became evident that the dilatation of the 
valve with the single balloons (then commercially available) was inferior to the double balloon 
technique. 6 The first groups of patients who had their mitral stenosis treated were generally 
younger people with non-calcified rheumatic mitral stenosis. 
Palacios7 and McKay8 in separate reports in 1986 described balloon dilation of calcified mitral 
stenosis with good immediate effect - McKay's patient was 75 years old. (The patients were 
unable or reluctant to undergo surgery). 
In an attempt to avoid the perceived dangers of balloon septostomy of the atrial septum, Babic 
and co-workers developed a retrograde approach whereby the dilating catheter was drawn 
back across the mitral orifice via the femoral artery - this technique required both femoral 
arteries and both femoral veins to be punctured as well as a transseptal puncture. The long 
guide wire (which stretched from the right femoral vein across the atrial septum, through the 
mitral valve and out of the left femoral artery via the aortic valve) was said to stabilize the 
dilating balloon and allow for inflation of the balloon away from the submitral apparatus. 9 
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This technique has been further modified to allow retrograde placement of the balloon without 
a transeptal puncture. 10 
Other balloon devices originally developed for pulmonary valve dilatation were also utilised 
in mitral valvotomy - the 'bifoil' and 'trefoil' devices offered the potential advantage of two 
or three smaller balloons with a large total area which could be introduced on a single 
catheter. 11 
A combination of the trefoil balloon with the 'conventional' balloon (such as those used by 
Lock and Palacios) to provide better stability has been described. 12 
At present the Inoue and double-balloon techniques appear to be the most commonly used 
techniques for balloon mitral valvuloplasty and series utilising these techniques account for 
the bulk of the published literature. 
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CHAPTER 3 
METHODS OF BALLOON MITRAL VALVULOPLASTY 
At least four terms - valvotomy, valvulotomy, commissurotomy and valvuloplasty - are used 
to describe the treatment of mitral stenosis with a balloon catheter. The relationship of the 
new technique to the surgical method it replaces has resulted in the suggestion that 
valvulotomy or commissurotomy are the more appropriate terms. 1•2 The Greek for the verb 
to mould or form gives rise to the suffix '-plasty' whereas the Greek for the verb to cut gives 
rise to the suffix '-tomy'. 2 Valvulotomy and valvotomy are essentially synonymous since 
'valvular' and valvar are equivalent terms, the former being a North American term and the 
latter being a British term. 3 
Cheng argues that the term valvuloplasty is the appropriate term since mere cutting of the 
fused commissures is not all that is responsible for the eventual increase in valve area. 
Furthermore, he argues that valvuloplasty is a better generic term since the 'curing' of other 
stenotic valves is not always related to the splitting of commissures. (He refers in particular 
to the tearing of leaflets in pulmonary stenosis). 3 
I will use the term 'valvuloplasty' because it appears to be the most frequently used term in 
the published literature. 
As alluded to in the previous chapter, the demonstration that the stenosed mitral valve could 
be treated with balloon techniques lead to attempts being made in many centres to achieve 
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similar results. The techniques used related largely to the availability of commercially 
produced balloon devices. 
At Groote Schuur hospital two techniques have been used. The Bifoil and Trefoil balloons 
manufactured by Schneider and utilised for pulmonary valve dilatation were used before the 
Inoue balloon became commercially available. 
The performance of balloon valvuloplasty in the laboratory at Groote Schuur is not preceeded 
by administration of prophylactic antibiotics. (Palacios and Block recommend the use of a 
short course of dicloxacillin started before the procedure).4 Because balloon valvuloplasty is 
increasingly being performed in patients who are only NYHA Class II disabled, it is the 
laboratory's practice to omit diuretics for two days prior to the procedure since resting 
transmitral gradients in a patient with significant mitral stenosis may be negligible when the 
patient is well diuresed. In such patients the assessment of the haemodynamic effects of the 
balloon dilatation may otherwise be very difficult. 
The procedure is performed in the fasting state. A single dose of an anxiolytic drug 
(lorazepam or other equivalent drug dependent on the practice of that institution) is 
administered on the morning of the procedure. Apart from liberal use of local anaesthetic, 
additional analgesia is provided with titrated doses of intravenous morphine. Balloon 
valvotomy is labour intensive usually requiring two operators as well as two to three members 
of the ancillary staff. 
While a surgical team is not kept on standby during the performance of mitral balloon 
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valvuloplasty, the procedure is scheduled at a time when such facilities could be accessed with 
minimal delay should a severe complication ensue. It is suggested that balloon valvuloplasty 
should not be performed at institutions where a surgical facility is not available. 5 
THE BIFOIL AND TREFOIL TECHNIQUE 
Suitable patients undergo the procedure following an echocardiographic study and a left and 
right sided cardiac diagnostic catheterisation. In older patients, coronary angiography is also 
advised. An aortic root angiogram may be of use in those patients with significant additional 
aortic valve disease as well as mitral stenosis. (Should the patients require emergency 
surgery, additional information concerning aortic regurgitation and coronary artery disease 
will be of use to the surgeon). 
Initially these haemodynamic studies were performed prior to the performance of balloon 
valvuloplasty - however, with increasing experience, the haemodynamic study and the balloon 
dilatation are performed at the same 'sitting'. Turi advises that the former practice be 
continued to allow the haemodynamic and renal effects of any contrast agent to abate. 1 He 
does comment that because of the accuracy of echocardiography in assessing gradients the 
haemodynamic information obtained during valvuloplasty 'in young patients without other 
confounding issues' is sufficient. 1 
Left ventricular angiography will indicate the degree of mitral regurgitation present and 
allows the operator to judge the position of the mitral valve plane. 
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The initial therapeutic step, which the technique shares with the Inoue technique, consists of 
the performance of a transeptal puncture with a standard Brockenborough needle. An 8F 
Mullins sheath is advanced into the left atrium. A paediatric balloon catheter is then used to 
dilate the puncture site in the atrial septum. A large bore Swan-Ganz balloon tipped catheter 
is advanced into the left atrium and subsequently into the ventricle. 
A Cook 0.038 inch guidewire is then advanced via the channel of the balloon catheter and 
allowed to lie with its tip in the left ventricular apex. 
The Bifoil catheter consists of two 19mm (when inflated) diameter balloons on a single shaft 
and the Trefoil catheter consists of three 15mm balloons on a single shaft. 
A large bore sheath (16.5F) is passed into the right femoral vein and the balloon catheter 
passed through this device along the guidewire, crossing the atrial septum. The balloon device 
is positioned across the mitral orifice and inflated with diluted radiographic contrast. The final 
diameter of the inflated balloons was related (prior to the procedure) to the diameter of the 
mitral annulus on two dimensional echocardiography. 
A number of inflations are employed until the 'waisting' of the balloon (as seen on 
fluoroscopic screening when the inflated balloon device was positioned within the stenotic 
valve) disappears. The device is then removed and haemodynamic measurements repeated to 
allow calculation of the final mitral valve area. 6 
The double balloon technique is similar to the above technique, except that two guidewires 
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are passed into the left ventricle - in earlier procedures this necessitated two septal punctures. 
Specially designed catheters facilitate the passage of two guidewires through a single 
puncture. Two dilating balloons are passed sequentially along the guidewires and positioned 
across the mitral valve. Various combinations of balloon size (typically two 20mm diameter 
balloons) are used, according to patient size. 7 In patients with severe stenosis, a single balloon 
may be used to perform the initial dilatation. Other centres have used a combination of a 
more rigid catheter such as the Bifoil with a Mansfield type balloon in order to stabilize the 
dilating apparatus. 8 
THE INOUE TECHNIQUE 
Concern over the length of the shaft of the Schneider catheter beyond the end of the dilating 
balloons (and the potential of this stem to tear the ventricle during balloon inflation) led to 
the replacement of the Schneider technique with the Inoue Balloon catheter technique when 
this became commercially available in South Africa. 
The Inoue balloon differs from all other balloons utilised in interventional cardiology in that 
the rubber balloon is designed such that the tip of the balloon inflates first and then is 
followed by the inflation of the rest of the balloon when increasing volumes of dilute contrast 
are added to the balloon. This allows the balloon to be placed by 'flow-direction' - in other 
words, the partially inflated balloon can be floated across the stenosed mitral valve without 
a guidewire having to be placed into the ventricle - decreasing the risk of ventricular 
perforation. 
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The Inoue balloon is, in a sense, a balloon within a balloon. Two layers of latex rubber 
tubing are separated by a layer of nylon micromesh which reinforces the structure. The 
balloon is able to be inflated in three stages as a result of rubber bands wound tightly around 
the mesh in the centre of the balloon and more loosely around the proximal mesh. The 
balloon can thus be inflated in the following sequence: tip first, then proximal section and 
then the complete balloon. 9 The balloon is mounted on a 12F polyvinyl chloride catheter with 
two coaxial lumina. 5 
The procedure starts with a transeptal puncture with a conventional Brockenborough needle. 
The site of puncture varies from the traditional site (the fossa ovalis) used when a transeptal 
puncture is performed during diagnostic catheterisation. To compensate for the increase in the 
size of the left atrium and bulging of the fossa ovalis the puncture in the septum is lower than 
the conventional technique. 
In order to puncture the atrium in the correct place, Inoue and co-workers have suggested 
puncturing the atrial septum about one vertebral body above the inferior border of the left 
atrium. (The atrium can usually be visualised with fluoroscopy, but Inoue et al suggest that 
the levophase of a right atrial contrast injection may provide a useful map of the left atrium). 5 
The atrial puncture is usually made with the Brockenborough direction indicator at 6 o'clock 
rather than the traditional 4 o'clock position. In addition the pigtail catheter above the aortic 
valve and the Swan-Ganz catheter in the main pulmonary artery (which are not removed after 
the haemodynamic study from the left femoral vessels) are used as landmarks to prevent 
accidental aortic puncture. It has been suggested that transoesophageal echocardiographic 
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techniques may be of use during the transeptal puncture since the atria, atrial septum and 
needle can be identified without difficulty. 10 The positioning of the balloon may also be 
facilitated as may the detection of mitral regurgitation. 
With successful left atrial puncture, the Mullins or Brockenborough catheter is advanced into 
the left atrium and the puncturing needle withdrawn. The simultaneous recording of left atrial 
and left ventricular pressures is then performed to confirm the transmitral gradient. (Cardiac 
output is usually measured by thermodilution and the Fick principle at the time of the 
haemodynamic study). 
Following successful placement of the catheter, heparin is administered intravenously. 
Generally a 'rule of thumb' bolus is used (10 000 units for larger patients and 7 500 for 
smaller individuals). (Inoue suggests that a dose of 150u/kg is used in a patient who is not 
maintained on Warfarin). 
A special 0.025 inch stainless steel guidewire which has a coiled floppy tip is passed into the 
left atrium. The floppy tip should be seen to coil within the atrium - confirming that the 
guidewire has not entered a pulmonary vein. The Mullins or equivalent catheter is then 
removed. 
The Inoue technique dispenses with the need for a special dilating balloon for atrial 
septostomy dilatation by using a rigid 14F polythene dilator. This dilator is used to dilate both 
the subcutaneous tissues and the right femoral vein as well as the interatrial septum. The 
dilatation of the femoral vein allows the balloon to be passed transvenously without the need 
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for a venous sheath. The dilator is then passed over the stainless steel guidewire and advanced 
to dilate the interatrial septum. 
The maximum diameter for the balloon catheter is assessed prior to the procedure by using 
the empirically derived relationship developed by Hung et al. 11 Balloon reference size is 
obtained by measuring patient height (in centimetres) and rounding off to the nearest 10, 
dividing by 10, and adding 10 to that result. Balloon catheters are available in a range of sizes 
(according to the maximum diameter of the fully inflated balloon). 
The central lumen of the catheter allows passage of a thin 18g metal tube which fits snugly 
into the device. The metal hub is then pushed forward and locked into the hub of the catheter. 
This stretches the distal end of the balloon increasing its length from 45mm to 60mm. Inoue 
describes the elongated balloon as 'slenderized'. 5 The thin distal balloon can then be advanced 
into the femoral vein and across the atrial septum. 
The elongated balloon is advanced over the guidewire and brought to lie with the distal end 
in the left atrium and a 0.038 inch high torque J-tipped spring wire stylet is introduced into 
the catheter. This catheter allows the tip of the balloon to be steered accurately while in the 
atrium. The guidewire is fairly stiff resulting in an exactly equivalent movement of the 
catheter with each movement of the guidewire at the catheter hub. 
The metal tube is withdrawn incrementally allowing the balloon catheter to follow the curve 
of the coiled atrial guidewire with the balloon coming to lie entirely within the left atrium. 
The balloon is finally advanced along the guidewire to lie in the vicinity of the mitral orifice 
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before the coiled guidewire is removed. The gradual withdrawal of the metal tube, which 
fully elongates the balloon, is important since the aggressive introduction of the entire 
elongated balloon into the left atrium may result in the bending of the coiled guidewire by the 
balloon tip against the roof of the left atrium. This bending of the guidewire may make its 
removal impossible. 5 
The spring wire stylet is now used to aim the tip of the balloon at the mitral orifice. The tip 
of the balloon is then inflated with a few millilitres of contrast. A combination of 
counterclockwise motion of the guidewire and gentle retraction of the whole catheter usually 
results in the partially inflated balloon starting to enter the mitral orifice. (Occasionally, the 
mitral valve may be so severely stenosed that the distal balloon tip cannot be inflated at all). 
A final combination of movements executed simultaneously will result in the balloon passing 
into the left ventricle. These movements are the withdrawal of the stylet some 5cm (while 
maintaining full counterclockwise rotation) and the advancing of the balloon some 5cm. This 
combination of movements (described by one operator at the Groote Schuur laboratory as 
'twisting the neck of a chicken') is usually successful. If the shape of the atrium is such that 
the tip of the balloon does not point along the axis of the mitral orifice when the manoeuvre 
is started but is perpendicular to it, another manoeuvre known as the loop method is used. 
The stylet is withdrawn slightly from the tip and the entire catheter is rotated 360° clockwise 
resulting in the end of the catheter looping in the atrium and directing the tip of the balloon 
into the mitral orifice. 
Variations of the technique are utilised to facilitate balloon insertion when the transseptal 
puncture is made too high or too low or when the atrium is very large. 5 
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With the balloon tip within the left ventricle, the operator is now in a position to assess 
whether the balloon is clear of the subvalvar structures or not. Usually free movement of the 
balloon within the ventricle is easily demonstrated. The inflated tip is then pulled back to 
lodge in the mitral orifice and a second operator will then continue the inflation of the 
balloon. If the balloon is in the correct position a waist will be noted at the centre of the 
inflating balloon. If commissural splitting is achieved, this waist is seen to 'pop' with full 
inflation of the balloon. 
In a manner analogous to the way in which closed mitral valvotomy surgeons suggested that 
the Tubbs dilator should be opened to its full diameter in increments, Inoue has suggested that 
a series of balloon inflations should be performed starting at a smaller final diameter. This 
is said to lower the incidence of balloon induced mitral regurgitation. 5•12 
The balloon is withdrawn into the left atrium and the central channel of the catheter (from 
which the stylet is now removed) facilitates repeated haemodynamic measurements. 
In the Groote Schuur catheterisation laboratory another observer (usually a catheterisation 
laboratory fellow) will listen for the presence of mitral regurgitation with a stethoscope 
following each inflation of the balloon. It has become the practice to stop the dilatation 
procedure if mitral regurgitation is detected by auscultation (even if an adequate reduction in 
gradient has not been felt to have been achieved). 
The removal of the balloon across the atrial septum is facilitated by reinsertion of the coiled 
guidewire to lie within the atrium and repeat 'slenderizing' of the balloon. The entire 
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elongated balloon is then removed from the femoral vein following the performance of a left 
ventricular angiogram and the administration of protamine to reverse the effects of the heparin 
administered following the transseptal puncture. 
Following haemostasis in the femoral vessels the patient is returned to the ward. Initially these 
patients were observed in the cardiac intensive care unit for 24 hours. However, with 
increasing operator experience, these patients are felt not to need intensive post-procedure 
monitoring unless a significant complication has occurred during the procedure or the 
procedure has been unusually difficult and prolonged. 
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CHAPTER 4 
THE SELECTION OF PATIENTS FOR VALVULOPLASTY 
Since the selection criteria for surgical therapy in patients with mitral stenosis were already 
well established, 1•2 it is not surprising that the original patients selected for balloon 
valvuloplasty should have been chosen according to the same criteria. Inoue' s original patients 
were felt to have tight mitral stenosis with changes on echocardiogram equivalent to the better 
grades of the pathological grading system of Sellors et al. 3 (In the grading of Sellors et al, 
grade 1 is equivalent to the 'mobile' valve). 4 
Al Zaibag's patients were also carefully selected to include only young adults with pliable 
valves and no evidence of atrial clot, subvalve disease or mitral calcification. 5 In addition 
patients with mitral regurgitation were excluded. As mentioned in an earlier section, the initial 
North American experience was obtained in patients who were unable to have surgery. 6 
With increasing experience, balloon dilating procedures have been used in patients with more 
complex valvular pathology or in patients who were considered high risk for valve 
replacement because of additional cardiac or extracardiac pathology. 7•8 
The patient with clinically determined tight pliable mitral stenosis, who has no more than 
trivial mitral regurgitation and does not have marked valvular calcification on X-ray, should 
therefore be considered for balloon valvuloplasty. Significant mitral regurgitation is a contra-
indication to balloon valvuloplasty. This practice is derived from the surgical results in 
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patients with mitral stenosis and regurgitation who underwent open mitral valvotomy and were 
shown to fare less well than patients with pure mitral stenosis. (Such patients are generally 
excluded from such surgery). 9 Balloon valvuloplasty has the potential to increase the degree 
of regurgitation. 10 Patients with additional moderate aortic regurgitation are not excluded from 
mitral valvotomy. 11 
Block has listed contra-indications to balloon valvuloplasty. 12 The contra-indications apply 
chiefly to those patients in whom transseptal puncture would be difficult or potentially 
hazardous. The patient with a left atrial thrombus, marked dilatation of the aortic root, giant 
right atrium, rotational anomaly of the heart or great vessels, or thoraco-lumbar scoliosis 
would therefore not be suitable. He added recent thromboembolic event, 2 + or more mitral 
regurgitation, left ventricular thrombus and associated surgical coronary or other valve disease 
to this list. 
It would also seem logical to add the conventional contra-indication to diagnostic angiography 
to the list, since the dilatation procedure involves puncturing of vessels and the use of contrast 
agents. Most of these contra-indications are relative - correct assessment of risk and potential 
benefit and careful planning of the procedure in the patient with a history of allergy to 
contrast, renal failure or associated illness may allow the procedure to proceed without 
event. 13 
Initially patients with a history of embolic events or documented atrial thrombi were excluded 
from valvuloplasty. Hung and co-workers reported resolution of left atrial thrombus in two 
patients (examined with transthoracic echocardiography) treated with warfarin who 
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subsequently underwent balloon valvuloplasty. 14 Further work from the same group (using 
transoesophageal techniques) led to them suggesting a policy of 4 to 6 weeks of 
anticoagulation with warfarin prior to valvuloplasty. 15 Hung feels that this policy is safe even 
in patients in whom the atrial thrombus has not been shown to resolve since it has been 
demonstrated that when the Inoue technique is used thrombus within the left atrial appendage 
can be avoided. 16 
Thrombus in the vicinity of the intra-atrial septum or the mitral valve is still felt to be an 
absolute contra-indication to balloon valvuloplasty .16 The symptomatic patient with a left atrial 
thrombus who cannot wait for definitive therapy should also undergo surgical valvotomy. 
Transoesophageal echocardiography is far more sensitive in detection of atrial clot and it has 
been suggested that patients undergoing balloon valvuloplasty should all be screened with this 
technique. 17 Turi points out, however, that many procedures have been performed without 
preprocedure transoesophageal echocardiography and there has been a very low incidence of 
embolism. The detection of left atrial clot is still felt by some authors to be an absolute 
contra-indication to balloon valvuloplasty. 18 
Performance of valvuloplasty may be complicated by an increased risk of bleeding as a result 
of anticoagulation in patients with atrial fibrillation. At Groote Schuur hospital the patient's 
International Normalised Ratio is allowed to fall below 2 (by omitting warfarin) before the 
technique is performed. Other authors (such as Hung) continue standard anticoagulation and 
simply administer less heparin at the time of procedure. 16 
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As alluded to in an earlier section, initial procedures were confined to a younger age group 
with 'straightforward' mitral stenosis. Age, per se, is not a contra-indication to balloon 
valvuloplasty. The older patient is, however, more likely to have significant valve 
calcification and a higher rate of unsuccessful procedures and complications related to the 
procedure. 19 
Previous surgical commissurotomy (either open or closed) is not a contra-indication to balloon 
valvuloplasty and most major series (independent of technique) contain a number of patients 
who have undergone surgical commissurotomy. 20 Results of the procedure in this group are 
equivalent to those in patients having valvuloplasty as an initial event. 
Disease of other valves is not necessarily a contra-indication to balloon valvuloplasty of the 
mitral valve. The dilatation of a stenosed aortic valve at the procedure has been reported. 21 
TIIE ROLE OF ECHOCARDIOGRAPHY IN PATIENT SELECTION 
It is a moot point whether echocardiographic assessment has any value other than excluding 
atrial clot and establishing baseline pathology in the patients with tight, pliable mitral stenosis 
who form the majority of patients undergoing valvuloplasty in the developing world. Good 
clinical results were achieved with closed valvotomy without the benefit of echocardiography. 
The proponents of complex echocardiographic scoring techniques which allow prediction of 
good echocardiographic results should retain perspective. The best echocardiographic result 
still only represents palliation. Furthermore a less impressive echocardiographic result is not 
necessarily failed therapy but less effective palliation. 
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Two-dimensional echocardiography allows visualisation of the mitral valve and associated 
structures in the majority of patients. 22•23 With two-dimensional echocardiography it is possible 
to measure the mitral valve area by planimetry. This planimetric valve area usually 
corresponds to the valve area derived from catheterisation data with the Gorlin formula. 24 The 
echocardiographic examination also allows assessment of other valvular abnormalities. 
Doppler derived measurements of pressure (derived from measurements of velocity) correlate 
well with values determined by invasive study. 25 Measurement of pressure half-time (the time 
taken for the initial transmitral gradient to fall to halt) is useful in patients in whom adequate 
cross sectional views of the valve cannot be obtained to assess valve area by planimetry. 26 
Measurement of the mitral annulus diameter during an echocardiographic examination may 
be needed to predict final balloon size (and hence the initial balloon size) when valvuloplasty 
is performed with techniques not utilising the Inoue balloon device. 27 The authors were able 
to determine that a ratio of 1 when comparing final balloon diameter (in their case the sum 
of 2 balloons) to the annulus diameter resulted in the best results as regards final balloon 
diameter. A ratio of greater than 1.1 resulted in the occurrence of significant mitral 
regurgitation. 
The detection of mitral regurgitation with conventional Doppler pulsed-wave, continuous-wave 
or colour flow techniques is easily performed. However the quantification of regurgitation is 
difficult and may not compare to angiography (which could itself be considered to be a 
tarnished 'gold standard') except when regurgitation is trivial or severe. 28 Recent 
modifications of method (proximal flow convergence) may permit colour flow Doppler to 
44 
become equivalent to angiography in the assessment of regurgitation. 29 
In patients in whom adequate transthoracic information cannot be obtained or in whom the 
presence of intra-atrial clot is suspected and cannot be excluded, transoesophageal 
echocardiography may be of use. An elegant comparison of transoesophageal and 
transthoracic techniques in patients with mitral stenosis undergoing valvuloplasty has been 
performed by Rittoo and colleagues. 30 As would be expected because of the better quality of 
transoesophageal imaging, the views of the mitral valve were more detailed than those 
obtained with precordial imaging. Nevertheless, adequate information could be obtained 
transthoracically. The assessment of the subvalvular structures was easier with transthoracic 
views because of difficulty with obtaining transgastric views of the heart. The difficulty is 
apparently related to the size of the left atrium in patients with mitral stenosis. 
Transoesophageal techniques are superior for assessing left atrial clot and left-to-right shunts 
at an atrial level. 
The echocardiographic grading system of Abascal, Wilkins and co-authors from Boston has 
become widely used. Although initially reported for a series of only 22 patients, subsequent 
work has 'validated' the system 18•31 
Four major categories are used to describe the structure of the mitral valve and a grading 
system (which is subjective) is used which attaches to each category a maximum score of four 
points. In the work of Abascal a score greater than 12 was associated with poor short- and 
intermediate-term results and a score less than 8 is associated with the best results. The 
scoring system is reproduced below. 
Table 1 
Grade 
2 
3 
4 
45 
Grading of mitral valve characteristics from the echocardiographic 
examination (Modified after Wilkins GT et a/31) 
Mobility Subvalvar 
thickening 
Thickening Calcification 
Highly mobile valve Minimal thickening Leaflets near normal A single area of 
with only leaflet tips just below the mitral in thickness increased echo 
restricted leaflets brightness 
Leaflet mid and Thickening of Mid-leaflets normal, Scattered ares of 
base portions have chordal structures considerable brightness confined 
normal mobility extending up to one shortening of to leaflet margins 
third of the chordal margins 
length 
Valve continues to Thickening Thickening Brightness extending 
move forward in extending to the extending through to the midportion of 
diastole mainly from distal third of the the entire leaflet the leaflets 
the base chords 
No or minimal Extensive thickening Considerable Extensive brightness 
forward movement and shortening of all thickening of all throughout much of 
of the leaflets in chordal structures leaflet tissue the leaflet tissue 
diastole extending down to 
the papillary 
structures 
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The scoring system is usually easily used by echocardiographers although the complete 
assessment of the subvalvular apparatus requires unorthodox views. 31 Although the scoring 
system is useful to predict a 'good' or 'bad' outcome, it has limitations which both the 
originators of the system and its critics have pointed out. The score does not correlate well 
with the absolute increase in valve area. 32 In addition, the four components are arbitrarily 
given equal weighting. Subsequent multivariate analysis shows that valve thickness alone was 
the best predictor of increase in valve area. 
Reid and co-workers used a quantitative system of measurement of mobility and thickness in 
their analysis and showed that the quantative assessment of mobility was superior to subjective 
scoring in predicting final valve area after double balloon valvuloplasty. 33 As with Abascal 
and co-workers, they conclude that echocardiographic assessment of subvalvar disease and 
calcification is complicated and difficult to quantify. Leaflet thickening, calcification and 
subvalvar disease may contribute to mitral valve leaflet mobility. 
Chen and colleagues modified the Boston group's scoring system by assigning the maximum 
score for subvalvar disease only if severe disease was observed in all subvalvar structures and 
if there was absence of separation of the chordae arising from the anteromedial and 
posterolateral papillary muscles - grade 2 subvalvar change becoming equivalent to grade 3 
of the Boston grading. Subsequent analysis resulted in subvalve apparatus disease being 
identified as an independent risk factor for a suboptimal result. (Total score did not predict 
a poor result). In their group of patients which were younger than Wilkins' group a high 
score was not necessarily related to subvalve disease. 27 It is felt that the underestimation of 
disease in the submitral apparatus may contribute to post dilatation mitral regurgitation. 34 
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The use of scoring as the sole means of 'triaging' candidates for valvuloplasty is not 
recommended - Abascal and co-workers point out that 'a high echocardiographic echo score 
does not preclude the possibility of a good result. '32 Score may, however, be a predictor of 
recurrent stenosis. 35 
Otto et al have reviewed the use of echocardiography in those patients entered into the 
National Heart, Lung and Blood Institute registry of valvuloplasty techniques in the United 
States. 36 Unlike the 'method' papers which have evaluated individual echocardiographic 
techniques, the use of these techniques in the registry may represent the use of 
echocardiography in the real world. All echocardiographically determined measures of area 
and gradient correlated poorly with their haemodynamic equivalents. The 'non-simultaneous' 
performance of techniques, observer bias and variations in technical expertise, as well as 
changes in transvalvular flow contribute to this poor correlation. Nevertheless, after 
valvuloplasty, the magnitude of change is similar whatever technique is used. In this group 
of patients the difference between methods was less than 0.5cm2 in 96% of patients. 36 
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CHAPTER 5 
THE PATHOLOGICAL CONSEQUENCES OF BALLOON VALVULOPLASTY 
The splitting of one or both fused commissures is the presumed mechanism whereby the 
performance of closed surgical valvotomy is able to relieve mitral stenosis. 1 The mechanism 
whereby balloon dilatation relieves mitral stenosis could have been predicted to be similar. 
Inoue demonstrated that commissural splitting occurred in a series of patients undergoing open 
mitral valvotomy where a balloon was used intra-operatively to dilate the valve. 2 
Kaplan and co-workers, in an in vitro study of excised stenotic valves (removed from patients 
undergoing valve replacement), demonstrated that commissural splitting occurred when a 
valvuloplasty balloon was inflated within the stenotic valve. Interestingly, calcification of the 
leaflets did not preclude splitting of the commissures. The most important caveat to their 
findings (noted by the authors) was that the in vitro valves did not include an intact submitral 
apparatus. Therefore the effect of balloon dilatation on the subvalvular apparatus could not 
be determined. 3 
Ribeiro and colleagues were able to demonstrate similar findings using a double-balloon 
technique. (Interestingly, they were able to show that double balloon techniques resulted in 
a larger resultant area than single balloons). Their findings were documented in excised valves 
from patients undergoing valve replacement. A portion of these valves ( 41 % ) had attached 
subvalvular chordae but splitting of these structures was not seen. 4 McKay and co-workers 
documented similar findings in postmortem dilatations of valves from patients who had 
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evidence of mitral stenosis at autopsy. 5 
Block's group provided similar results in two patients who had undergone valvuloplasty. One 
patient had died following an unrelated septicaemia and at autopsy commissural splitting was 
demonstrated. In their second patient, who had mitral valve replacement, they were able to 
demonstrate that balloon dilatation had not achieved the desired effect because of severe 
subvalvular disease. Although the commissures had been slightly split, the subvalvular fibrosis 
had not been affected. 6 
Reid and co-workers were able to demonstrate that splitting of the commissures occurred in 
successful balloon valvuloplasty by careful cross-sectional echocardiographic studies before 
and after the balloon procedure. 7 They argued that in their patients the documented increase 
in the intercommissural distance was not as a result of stretching of the valve leaflets but as 
a result of commissural tearing. They also documented that poorer results occurred in patients 
with calcification of the commissures - the commissures failed to split if both were calcified. 
In all of the studies discussed above, tears in the leaflets had been produced in a small 
proportion of the valves. It was postulated that similar tearing in life would produce mitral 
regurgitation. 3•4•5 In another study Sadee and Becker demonstrated that significant subvalvular 
disease was associated with an increase risk of tearing. In these patients the tearing did not 
originate in the leaflets but in the fused chordal structures. 8 In life, Vahanian et al reported 
only paracommissural tears in the eight patients in their series who required mitral valve 
replacement following balloon valvuloplasty. All the patients had extensive valvular or 
subvalvular disease. 9 Similar findings have been noted with the Inoue technique. 10 
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CHAPTER 6 
COMPLICATIONS 
The 'average' balloon valvuloplasty consists of two phases, a confirmatory diagnostic 
catheterisation and the valvuloplasty procedure itself. Attribution of complications to the 
catheterisation rather than the valvuloplasty is probably not valid, since it can be argued that 
no invasive data are needed when echocardiographic data are available. Catheterisation was 
not always performed before closed mitral valvotomy in the pre-echocardiography era. 1 
The incidence of complications may differ markedly according to the population selected for 
the procedure. 
The reports of misadventure can be divided into three groups: 
1) Where complications are reported as part of a report of a centre's or group's 
experience; 
2) Where complications are of interest or very unusual; and 
3) In 'registry' type reports which focus on data collected prospectively relating 
specifically to complications and which represent the work of a number of centres and 
operators. 
In a large collection of prospectively acquired data, the 'serious' complication rate was 12 % .2 
'Serious' included death, cardiac perforation, cardiac tamponade, the need for emergency 
surgery, embolic events (including cerebrovascular accidents), myocardial infarction, 
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pulmonary embolus, and acute severe mitral regurgitation. 
The perception that certain events are important complications of a procedure may alter with 
time. The iatrogenic atrial septal defect is such an event - its incidence is widely reported, 
yet its presence is of little relevance (see below). Techniques of measurement may also differ 
making it difficult to compare groups; for example, methods of quantitation of mitral 
regurgitation and left to right shunting vary widely. Furthermore the publication of 
complication rates in older 'First World' populations may not have much relevance to the 
performance of valvuloplasty in a homogeneous group of patients in a developing country. 
Death during the procedure or in the 30 days following the procedure (early mortality) ranges 
from O % to 3 % according to reports detailing events in more than 400 patients each. 2•3•4 
The differences between groups as regards mortality can be attributed to selection criteria as 
well as the number of operators involved. Inoue and Hung reported the results of the 
procedure in 527 patients who had valvuloplasty procedures performed by 8 operators. 3 
Vahanian's series of 600 patients underwent the procedure at one hospital. 4 In contrast, the 
largest series reported from the United States details the experience in 24 sites with at least 
as many operators. 
In all of these reports, initial experience was gained with carefully screened patients who 
would have been considered ideal candidates for surgical commissurotomy. With increasing 
experience, less 'favourable' patients were selected. All series include small numbers of 
patients who were at high risk for surgery as well as balloon valvuloplasty. The incidence of 
death (and all complications) is noted to decrease with increasing operator experience (the 
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'learning curve') and with increasing patient numbers at individual centres. 2•5 In the NHLBI 
registry, centres who performed valvuloplasty procedures on less than 25 patients had 6 times 
the mortality of centres involved with more than 100 patients. 2 
The reasons for early mortality are diverse. Ventricular perforation, either as a result of the 
balloon device perforating the ventricle or secondary to the transseptal puncture is the most 
common reason for procedural death in the NHLBI series. Other problems such as coronary 
emboli, death during mitral valve replacement after the creation of severe mitral regurgitation 
and persistent pulmonary hypertension also resulted in deaths. 2•4 A high echo score (greater 
than or equal to 13) was shown to be a predictor of mortality when the data was subjected 
to multivariate analysis. 2 
In the NHLBI registry, half the early deaths were related to the procedure. The other deaths 
were predominantly non cardiac and are probably the result of the procedure being attempted 
in high risk candidates. The rate of death in patients of greater than 70 years of age was 14 % 
versus 2 % in younger patients. This trend (higher mortality in older patients) has been 
confirmed by other authors. Le Feuvre et al showed that their patients older than 70 years 
(only 28 patients - 10% of their experience) had a mortality of 12 % versus the 0.8 % mortality 
of the rest of the group. Complications in general were common in the older group (27% vs 
9%).6 
It is tempting to ascribe mortality to a particular technique or balloon type. Although the large 
series of 527 patients reported by Inoue and Hung was free from mortality, two other series 
reporting events in more than 200 patients each have recorded 0.5 % mortality when the Inoue 
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balloon was used. 7·8 Both deaths occurred in patients in extremis prior to the procedure 
however. 
Perforation of a cardiac chamber is reported to occur in 4% of procedures. 2 In the registry 
the perforation was a result of balloon or guidewire perforation and not as a result of 
attempted transseptal puncture. In the North American Inoue registry, the transseptal puncture 
resulted in cardiac perforation in 1.5 % of procedures. 7 
The use of non-transseptal (ie retrograde) techniques is associated with less risk of cardiac 
perforation, as would be expected. In a series of 150 patients reported from Greece, the 
incidence of cardiac perforation was 0%. 9 The larger series of Babic et al, in which a 
transseptal puncture was created to stabilise a retrogradely introduced balloon device, had a 
2 % incidence of cardiac perforation. 10 
Cardiac perforation is not always associated with tamponade and may be treated expectantly. 
In the NHLBI registry all perforations resulted in tamponade. 2 In the North American Inoue 
study one of three perforations did not result in cardiac tamponade. In the series of Vahanian 
and Inoue, asymptomatic perforation is not documented as a separate entity. Proponents of 
the Inoue balloon claim that the absence of a left ventricular guidewire decreases the 
incidence of ventricular perforation. 3 
Bassand et al' s series documented a higher incidence of tamponade in the double balloon 
group as opposed to the Inoue group (3/161 vs 0/71). 11 In the series of Abdullah et al, again 
comparing these two balloon types, the incidence of tamponade was identical (1/60 vs 1/60). 12 
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In the randomised trial from Park and colleagues no instances of tamponade were reported 
in either group. 13 
The potential to cause severe mitral regurgitation is common to all types of technique. The 
mechanisms whereby severe regurgitation is caused have been alluded to in a previous 
section. An increase in mitral regurgitation (measured either by left ventricular angiography 
or echocardiography) by at least one grade (using conventional subjective grading techniques) 
occurs in up to 51 % of patients undergoing balloon valvuloplasty. 14 Severe mitral 
regurgitation defined variously as an increase of greater than 2 or 3 grades, however, occurs 
in far fewer patients (6.6% in Hernandez et al group, 1.9% in Inoue/Hung's group, 3.8% of 
Vahanian' s group). Between 50 and 100% of these patients will require mitral valve 
replacement. 3•4•14 Most series report a small number of patients (usually less than 5 % ) whose 
degree of mitral regurgitation is considered to be less immediately post procedure. 8•12 
The majority of patients with lesser degrees of mitral regurgitation tend to remain unchanged 
with time. 15 •16 In the reports of Ribeiro et al and Pan et al, approximately 10% of patients 
with some degree of mitral regurgitation post procedure (not necessarily new) experienced 
further change during the year after valvuloplasty. 2 to 5 % developed grade 3 + or worse 
mitral regurgitation. 
Minor degrees of mitral regurgitation are well tolerated. 3 The propensity for a particular 
technique to cause more regurgitation has been debated. Hernandez and co-workers have 
argued that it is easier to cause mitral regurgitation with the Inoue balloon. The balloon is 
more readily placed across a deformed valve and could more easily result in subvalvular 
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apparatus damage. (In a severely deformed valve it may be impossible to obtain a stable 
position with the double balloon apparatus - hence inflation may not even be feasible). 14 
In the companson of techniques performed by Abdullah and co-workers there was no 
difference in the techniques as regards mitral regurgitation. 12 Undefinable variables such as 
experience and careful patient selection may have played a role. The randomised trial of Park 
et al reported similar results between balloon techniques as regards mild and severe 
regurgitation, although the authors deviated from the suggested step-wise approach and used 
a single inflation at optimum diameter. 13 (The effective balloon dilating area to body surface 
area ratio of 4 cm2/m2 as suggested for the double balloon technique was used). 
In three large series embolic events related to the procedure occurred in 0.6% to 3.3 % . 2,3,4 
These emboli were predominantly cerebral. In the NHLBI registry patients with a left atrial 
thrombus or previous embolic event were at higher risk of embolic events during the 
procedure. Increasing use of transoesophageal echocardiography and techniques of 
anticoagulation have the potential to decrease the incidence of such events. Thrombus or air 
may in addition occlude a coronary artery resulting in myocardial infarction. 2 
A plethora of publications have detailed the incidence of atrial septal defect post procedure. 
In all transatrial techniques a small hole should be present in the atrial septum post procedure. 
The detection of left to right shunting through the defect depends on the technique of 
measurement and differing perceptions of 'significance' (ie what represents a significant left 
to right shunt). Up to 14 % of patients will have a left to right shunt defect immediately post 
procedure if a Qp/Qs ratio of > 1.3 is used. 4 Very few of these shunts are clinically 
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significant.4 On the other hand colour flow imaging with transoesophageal techniques may 
demonstrate a left to right shunt in up to 95 % of patients examined post procedure. 17 
When Qp/Qs is derived from the difference in thermodilution cardiac output when the 
iatrogenic septal defect is occluded and when it is patent, the incidence of haemodynamically 
detected shunting approaches colour flow techniques. 18 The use of the Fick principle 
immediately post valvuloplasty has also been questioned, since many patient variables are 
changing at that time and oxygen consumption measurement may not be accurate. 19 
The size of the atrial septal defect is related to the catheter techniques utilized and the number 
of punctures made in the atrial septum. Fields and co-workers demonstrated (in vitro) that two 
punctures and simultaneous withdrawal rather than sequential withdrawal of catheters resulted 
in the creation of larger defects. 20 
The majority of atrial septal defects tend to close with time. 21 The persistence of a septal 
defect may relate to its initial size (and hence to the technique used) and to inadequate 
treatment of the stenosed mitral valve. 22 
Arterial complications necessitating surgical repair of the femoral artery are obviously more 
common in transarterial techniques. In the series of Babic and co-workers the reported 
incidence was 2 % . 10 In contrast, in the NHLBI registry the need for vascular surgery was 
0.4%.2 
Most studies report other complications such as the need for blood transfusion secondary to 
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bleeding from the femoral vein, prolonged hypotension and transient arrhythmias occurring 
in less than 10 % of patients. 2A, 23 Other rare complications have been documented (NHLBI) 
usually on a single case per series basis. 
The table below summarises the incidence of major complications in three series containing 
more than 400 patients each. 
Vahanian Inoue/Hung NHLBI 
Attempts n = 600 n = 527 n = 738 
Tech success n = 581 n = 515 n = 680 
Mortality 0.5% 0% 3% 
Severe MR 3.8% 1.9% 3% 
Tamponade 0.8% 1.5% 4% 
Emboli 3.3% 0.6% 3% 
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CHAPTER 7 
RESULTS OF BALLOON VALVULOPLASTY 
The measured assessment of the success of balloon valvuloplasty (a good 'technical result') 
is arbitrary and was based on initial experience and on the assumption that a valve area 
greater than 1.5cm2 represented moderate mitral stenosis. A change in mitral valve area of 
25 % was also added to measure improvement in valve area when valvuloplasty was 
performed in patients with larger valve areas. 1 Other authors have increased the area change 
to 50 % and added the absence of significant complications as a caveat. 2 Restenosis in the 
follow up period is also arbitrarily defined either as valve area less than 1.5cm2 and less than 
50% improved, compared to the valve area prior to the valvotomy (using the Gorlin 
formula). 2 Others define restenosis as 'loss of 50% of the initial gain with valve area < 
1.5cm2 on follow up'. 3 Although the wording of the definitions is different, theoretically they 
are equivalent. 
The need (and the ability) to measure mitral valve area non-invasively has highlighted 
discrepancies between non-invasive and invasively determined data. A significant weakness 
in publications comparing methods of measurement is the inappropriate use of the correlation 
coefficient or 'r' value, which should be used to test an association between two variables and 
not used to compare methods of measurement. 4 The comparison of methods is also 
complicated by non-simultaneous measurement. Furthermore, methods are often compared 
in small numbers of patients. 
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Prior to valvuloplasty, the valve areas calculated by planimetry, Doppler derived pressure 
half-time methods and the Gorlin formula are equivalent. Immediately following 
valvuloplasty, both Doppler derived methods and the use of the Gorlin formula to determine 
valve area may be inaccurate. Chen et al found that simultaneously measured Doppler valve 
areas were larger than the values obtained with the Gorlin formula immediately post 
valvuloplasty. The Doppler derived figure in their patients by 24 hours post procedure, was 
equivalent to the data obtained by repeat catheterisation. 5 Manga and co-workers found that 
the Doppler derived values were lower than the invasively derived values until the hole in the 
atrial septum was occluded with a balloon to remove any left to right shunting which would 
result in the cardiac output measurement being inaccurate. 6 (The pressure half-time 
measurements by Doppler were performed during the 24 hour period post valvuloplasty). In 
the work of Otto et al, detailing echocardiographic measurements in the patients in the 
NHLBI registry, valve areas post valvuloplasty were consistently lower than 
haemodynamically derived data. These studies were performed a mean of 38 hours after the 
procedure. 7 
Thomas et al pointed out that the Doppler derived values are potentially inaccurate, since 
analysis of the half-time equation should take changes in net chamber compliance and net 
transmitral gradient into account. These values change in opposite directions in the 
valvuloplasty setting and 'cancel each other out' as regards their effect on half time 
measurement. 8 Manga points out that the work of Thomas et al which involved in vitro 
analysis of the derivation of the simple 220/half-time formula did not take the potential role 
of the septal defect into account. The modifying influences on the half-time formula have 
presumably resolved by 24 hours at which time it is suggested that the Doppler derived values 
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are obtained. 5 
Planimetry of the valve using 2-dimensional echo has also been used in the assessment of 
valvuloplasty. 9 The technique has limitations in that adequate images of the valve are not 
obtained in every patient. 10 
In the presence of aortic regurgitation, the half-time measurement of mitral valve area can 
be inaccurate. 5 Nakatani et al offered an alternative method, using the continuity equation, 
to estimate mitral valve area in this situation. The measurement was equivalent to the Gorlin 
measurement immediately post the procedure and declined in the first 24 hours post 
procedure. (It was not compared to half-time measurements). 11 
The accuracy of echocardiographic or Doppler techniques is relevant since these methods are 
used to repeat estimations of the valve area during follow-up. Centres attempting to describe 
the incidence of restenosis in the follow-up period may discover that as with some patients 
following surgical commissurotomy, 'restenosis' in follow-up may simply be equivalent to 
failure to enlarge the originally stenosed valve and not time-related loss of gain in valve 
area. 12 
The haemodynamic changes effected during valvuloplasty tend to be similar whatever 
technique is used. The table below (Table 1) compares haemodynamic changes achieved in 
a number of series (for clarity standard deviation data have been omitted). All the valve areas 
are determined using the Gorlin formula. 
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Table 1 
Author Type Complete Success MVA MVA Grad Grad 
pre post pre post 
Hung I 216 77% 1.0 2.0 13 5.7 
Block D 432 79% 0.9 2.0 15 5 
Hermann I 200 72% 1.0 1.8 14 6 
Vahanian M 581 87% 1.1 2.2 11 2.2 
Inoue I 515 NA 1.13 1.97 11.9 5.5 
Babic R 294 100% 1.1 2.3 18 6 
NHLBI 85% 576 76% 1.0 2.0 14 6 
D 
Note: R - retrograde technique,/ - Inoue balloon, M - mixed series, D - double balloon, MVA 
- mitral valve area (cm2), grad - transmitral gradient(mm Hg) 
The changes in haemodynamic data between double-balloon and the Inoue techniques are 
equivalent. Both randomised13 and comparative series from the same centre have been 
reported in the literature. 14•15 
Changes in other haemodynamic measures such as left atrial pressure measurements, and 
cardiac output measures are also well documented. A typical change in left atrial pressure is 
24.2 ± 5.1 to 5. 7 ± 2.6. 16 Cardiac output tends to increase. (In the series of Hung et al 4.4 
± 1.4 to 4. 7 1/m ± 1.2). 16 These data are consistent between techniques. 14 In the small series 
of Manga et al where the septa! defect is occluded, the change in cardiac output by 
thermodilution was less than that seen when the atrial septa! defect was open. 6 
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Pulmonary artery pressure measurements tend to decrease following valvuloplasty3 but the 
magnitude of the change is much smaller than the change in the transmitral gradient in the 
same patient suggesting that either a degree of fixed pulmonary vascular disease is present 
or that these changes resolve more slowly. Patients with severely elevated pressure ( > 50mm 
Hg systolic) showed decreases in both pulmonary artery pressure and resistance, but both 
values remained supranormal. 17 
Alfonso and colleagues studied a group of patients with severe pulmonary hypertension 
(defined by them as > 60mm Hg systolic pulmonary artery pressure) who underwent 
valvuloplasty. Pulmonary artery pressure dropped from 77 ± 15mm Hg to 60 ± 17mm Hg 
immediately post valvuloplasty. (These figures were equivalent to the doppler derived values 
in these patients (73± 18 to 54 ± 14)). Follow-up data (in 43 patients) at a mean of 14 ± 
3 months showed that a pressure drop of at least 10mm Hg had occurred. (The small numbers 
limit the usefulness of the study, since 4 patients experienced an increase, and 13 experienced 
a decrease in pressure. In 18 patients tricuspid regurgitation could not be detected and hence 
pulmonary pressure could not be estimated). Dev and Shrivavasta obtained catheterisation data 
in a small series of patients at 1 week and 3 to 12 months after valvuloplasty and showed a 
drop post procedure and a further decline in vascular resistance at 1 week but no significant 
decline thereafter. 18 
In all series, clinical improvement is usually reported in terms of the change of the New York 
Heart Association functional class. The initial status of the patients may vary according to the 
population the patients come from, but the bulk of patients have class II or Ill symptoms. 
Occasionally class I patients undergo valvuloplasty, typically because of the expressed need 
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to fall pregnant. 19 
Generally the bulk of patients improve to class I or II. For example, in the series reported 
from Baragwanath hospital, in a population with a median age of 29 years, 65 % of the 
patients were in class III prior to the procedure, 6% in class IV, 28 % in class II, and 1 % in 
class I. After the valvuloplasty, 94 % were in class I or II with an improvement in functional 
class of one grade in 91 % . 19 
In the NHLBI series, where the patients had a mean age of 54 years 9 % of patients were in 
class I, 27% in class II, 51 % in class III and 13 % in class IV prior to valvuloplasty. 8 % of 
all patients did not have completed procedures. 85 % had improved one class by discharge 
with 62 % of patients in class I. 20 
The improvements in symptoms post valvuloplasty have been measured objectively and 
patients show increased effort tolerance on treadmill testing three months post procedure. 16 
Immediate improvement in exertional symptoms immediately after the procedure is however 
thought not to relate to immediate improvement in exercise capacity but to relief of excessive 
exercise ventilation. The changes in exercise capacity may take a few months to become 
evident and may relate to improved skeletal muscle functioning. 21 
The initial improvement tends to be maintained at follow-up. In the large French series of 
Vahanian et al3 consisting of 600 patients with a mean age of 43 years, 23 % were class II 
limited, 73 % in class III and 4 % in class IV. By 42 months of follow-up 72 % of the patients 
were in class I or II. 
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In a North American series, in which the majority of patients were treated with the now 
outmoded single Mansfield balloon technique, 5% were in class II, 60% in class III, and 34% 
in class IV. Following the procedure, 91 % of patients increased by at least one functional 
grade. The improvement was maintained so that at a mean follow-up of 36 months 96% of 
patients were still in class I or II. 22 
In the report of Chen et al the results of valvuloplasty in 85 patients who had been followed 
up from 43 to 79 months (mean 5 years) were analyzed. 23 No patients in that small group had 
died and 87 % were in class I at extended follow up. 23 
The results of balloon valvuloplasty have also been stated in terms of survival data. Vahanian 
et al have provided actuarial survival data extending to 42 months post procedure. 87% of 
their patients were alive, and 81 % were free of the need for re-operation. 3 
In a group of (350) patients from Spain who underwent valvuloplasty performed with a 
variety of methods, the 5 year actuarial event-free probability rate was 85 % with a 94 % 
probability of survival at that time. 24 
The North American series of Block and Palacios consisting of 320 patients, followed for a 
mean of 20 months, had a 92 % 4 year probability of survival. 87% of the patients at 4 year 
follow-up had not required mitral valve replacement. 83 % of the surviving patients were 
NYHA class I or II at 4 years. 25 
The recurrence of symptoms post valvuloplasty may relate to a technically inadequate 
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valvuloplasty (in this instance, a small increase in valve area which, although not reaching 
the arbitrary criteria for success, probably allowed amelioration of symptoms for at least a 
short interval), true restenosis of the valve and progression of mitral regurgitation present 
prior to the valvuloplasty or created during the procedure. 
In the small series of Palacios et al, in which a subset of 100 patients underwent re-
catheterisation at a mean follow-up of 13 months, the incidence of restenosis was 22 % . 26 
Block and co-authors attempted to document restenosis in their patients at 2 years of follow-
up. In the group re-catheterised, which may not have been representative of the whole series, 
50% of the patients showed restenosis (defined as a decrease of greater than 50% of the area 
gain). Interestingly, their echocardiographic evaluation showed areas not significantly different 
from shortly after valvuloplasty, highlighting previously mentioned difficulties with the 
measurement of mitral area. 27 
In an echocardiographic study of 66 patients from Saudi Arabia with a younger mean age than 
the North American patients, Ribeiro and co-workers reported an incidence of restenosis of 
9 % after 1 year of follow-up. (Restenosis was defined as mitral valve area of less than 1.5cm2 
with a minimum loss of 0.4cm2 of valve area gain). 6% of the patients were classified as 
having persistent residual restenosis (valve area < 1.5cm2). Despite the echocardiographic 
evidence for restenosis, nearly all of the patients were still in functional class I or class II. 28 
Mitral regurgitation post valvuloplasty may be the reason for deterioration in functional class. 
Severe regurgitation post procedure may not lead to valve replacement with patients being 
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successfully treated with medical therapy in the majority of cases. In the series of Hernandez 
et al, one third of the patients with severe mitral regurgitation underwent early valve 
replacement. 90% of the remaining patients had their symptoms controlled medically at a 
mean of 11 months of follow-up. 29 
The larger series have been subjected to statistical analysis in order to obtain predictors of 
early and late outcome. The series from the Massachussets General Hospital highlighted a 
number of categories on univariate analysis which predicted a worse early outcome -
including older age, NHY A class, previous surgical commissurotomy, atrial fibrillation, 
valvular calcification on fluoroscopy and existing mitral regurgitation. 25 The series of Hung 
and Inoue added large left atrial size and increased cardiothoracic ratio on chest X-ray as 
univariate predictors of a poor outcome. 30 
Multivariate analysis tends to identify valvar anatomy expressed either as the 
echocardiographic score or its components as the most important predictor of a good short-
term outcome. 3•25 •30 While a good score (8 or less) is associated with a higher probability of 
a good outcome, a higher score does not preclude a good outcome in terms of increase in 
valve area and the absolute score should probably not be used to predict the outcome of the 
procedure. 31 
The weighting of individual components of the echocardiographic analysis as a predictor of 
outcome has been discussed in an earlier section. Commissural morphology may have a more 
important role as a predictor of outcome than previously realised since the prediction that one 
or both fused commissures would split has been shown to be a better predictor of a good 
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outcome than the absolute score. 31 
Similar statistical inferences have been made to predict successful long term outcomes. Pan 
and co-workers identified atrial fibrillation, valve calcification or fibrosis and a previous 
commissurotomy as being associated with a higher risk for restenosis. This work is similar 
to the work of Palacios et al with echo score and atrial fibrillation predicting restenosis over 
a shorter follow-up period. 26 Advanced age, atrial fibrillation, mitral regurgitation prior to the 
procedure, increased pulmonary resistance and decreased ejection fraction were identified as 
being associated with the need for mitral valve surgery. Survival was predicted by younger 
age, larger valve area prior to valvuloplasty, sinus rhythm, pliable mitral valve and absence 
of mitral regurgitation as well as absence of calcification and decreased pulmonary resistance. 
On multivariate analysis atrial fibrillation and valve calcification at fluoroscopy were 
identified as predictors of poor long term success in a series reporting a 5 year follow-up. 24 
On this basis a patient with sinus rhythm and no valvar calcification could be predicted to 
have a 96% probability of event free survival at 5 years post procedure. A patient with valve 
calcification and atrial fibrillation is likely to have a 60% probability of event free survival. 
In the series of Hung et al the long term outlook for the patients with valvular calcification 
and subvalvular disease was also worse than in the patients with pliable valves. 16 
In the series of Cohen et al a score less than 8, a low left ventricular end-diastolic pressure 
and a lower NYHA class predicted event-free survival to 5 years on multivariate analysis. A 
patient with three favourable variables would have an 84% probability of event-free survival 
at 5 years as opposed to 13 % in a patient with no favourable variables. 22 
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An alternative means of analysing results is to examine results in individual categories in 
patients suspected of being less likely to benefit or at higher risk than the patient with an 
optimal valve. The elderly patient, the patient with a previous commissurotomy and the 
pregnant patient are examples of such patients. The elderly have been discussed in a previous 
section. The patients with a previous surgical commissurotomy are as likely to benefit from 
balloon valvuloplasty if their valvular anatomy is suitable. 32 Pregnant patients can be safely 
treated with balloon valvuloplasty. 33 
Just as the comparison of the older closed surgical procedure with the more modern open 
procedure was made difficult by variables in patient selection and evaluation, the comparison 
of balloon valvuloplasty to its surgical predecessors is difficult. With limited follow-up data 
in the large series available, the outcome in 'good' patients undergoing surgical 
commissurotomy is possibly better than patients undergoing balloon valvuloplasty. 34 
Attempts to perform randomised studies comparing surgical commissurotomy to balloon 
valvuloplasty have been made. As would be expected the total number of patients involved 
is small. In a study from Durban, utilizing haemodynamic estimation of valve area, balloon 
valvuloplasty using a bifoil catheter resulted in a larger valve area than closed 
commissurotomy using a Tubb's dilator. A total of 45 patients with a mean echo score of 6 
were entered into the study. 35 
Turi and co-workers randomised 40 patients in a similar study utilising the double balloon 
technique. In their patients the surgical and the balloon techniques produced equivalent results 
which were sustained at 8 months post procedure. A significant number of patients did not 
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return for follow-up lessening the impact of their results. 36 The same group has reported 
similar preliminary results at 3 years of follow-up in a group of patients treated with open 
surgical valvotomy or balloon valvuloplasty. 37 
The closed surgical technique and the balloon technique have been compared in a group of 
200 patients also. from India. By a mean of 22 months of follow-up results were equivalent 
as regards mortality, haemodynamic improvement and restenosis. 38 
In a study from Tunisia involving 30 patients in each group, open valvotomy was shown to 
be equivalent to balloon valvuloplasty and better than closed valvotomy at 4 years of follow-
up. 39 
All these randomised studies have been performed in patients with relatively pliable valves. 
The widespread use of the balloon technique in these areas is probably limited by economic 
reasons alone, since the cost of the disposables in the balloon procedure exceeds the cost of 
a surgical procedure. 36 
The patient with the less pliable valve may be better dealt with surgically. 34 This group of 
patients has not been studied in a randomised trial. 
Even if balloon valvuloplasty is not equivalent in terms of long term outcome to its surgical 
predecessors, this will probably not result in it being abandoned. The technique at worse 
offers a means to non-operatively relieve symptoms for a number of years and to defer the 
need for a general anaesthetic and a thoracotomy as well as decrease the need for medication. 
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In terms of 'the unnatural history of mitral stenosis' balloon valvuloplasty is another means 
of 'turning the clock back. 140 
REFERENCES FOR CHAPTER 7 
1. Abascal VM, Wilkins GT, O'Shea JP, Choong CY, Palacios IF, Thomas JD, Rosas 
E, Newell JB, Block PC, Weyman AE. Prediction of successful outcome in 130 
patients undergoing percutaneous balloon mitral valvotomy. Circulation 1990;82:448-
456. 
2. Herrmann HC, Ramaswamy K, Isner JM, Feldman TE, Carroll JD, Pichard AD, 
Bashore TM, Dorms G, Massumi GA, Sundram P, Tobis JM, Feldman RC, Ramee 
S. Factors influencing immediate results, complications, and short-term follow-up 
status after Inoue balloon mitral valvotomy: A North American multicenter study. Am 
Heart J 1992;124:160-166. 
3. Vahanian A, Michel PL, Cormier B, Ghanem G, Vitoux B, Maroni JP, Cazaux P, 
Acar J. Immediate and mid-term results of percutaneous mitral commissurotomy. Eur 
Heart J 1991;12:Suppl B:84-89. 
4. Bland JM, Altman DG. Statistical methods for assessing agreement between two 
methods of clinical measurement. Lancet 1986;1:307-310. 
5. Chen C, Wang Y, Guo B, Lin Y. Reliability of the Doppler pressure half-time method 
for assessing effects of percutaneous mitral balloon valvuloplasty. J Am Coll Cardiol 
1989;13:1309-1313. 
6. Manga P, Singh S, Brandis S, Friedman B. Mitral valve area calculations immediately 
after percutaneous balloon mitral valvuloplasty: effect of the atrial septal defect. J Am 
Coll Cardiol 1993;21: 1568-1573. 
7. Otto CM, Davis KB, Holmes DR, O'Neill W, Ferguson J, Bashore TM, Bonan R. 
Methodologic issues in clinical evaluation of stenosis severity in adults undergoing 
aortic or mitral balloon valvuloplasty. Am J Cardiol 1992;69:1607-1616. 
8. Thomas JD, Wilkins GT, Choong CYP, Abascal VM, Palacios IF, Block PC, 
Weyman AE. Inaccuracy of mitral pressure half-time immediately after percutaneous 
mitral valvotomy. Dependence on transmitral gradient and left atrial and ventricular 
compliance. Circulation 1988;78:980-993. 
77 
9. Abascal VM, Wilkins GT, ChoongCY, ThomasJD, Palacios IF, Block PC, Weyman 
AE. Echocardiographic evaluation of mitral valve structure and function in patients 
followed for at least 6 months after percutaneous balloon mitral valvuloplasty. J Am 
Coll Cardiol 1988;12:606-615. 
10. Come PC, Riley MF, Diver D, Morgan JP, Safian RD, McKay RG. Noninvasive 
assessment of mitral stenosis before and after percutaneous balloon mitral 
valvuloplasty. Am J Cardiol 1988;61 :817-825. 
11. Nakatani S, Nagata S, Beppu S, Ishikura F, Tamai J, Yamagishi M, Ohmori F, 
Kimura K, Takamiya M, Miyatake K. Acute reduction of mitral valve area after 
percutaneous balloon mitral valvuloplasty: assessment with the Doppler continuity 
method. Am Heart J 1991;121:770-775. 
12. Higgs LM, Glancy DL, O'Brien KP, Epstein SE, Morrow AG. Mitral restenosis: an 
uncommon cause of recurrent symptoms following mitral commissurotomy. Am J 
Cardiol 1970;26:34-37. 
13. Park SJ, Kim JJ, Park SW, Song JK, Doo YC. Lee SJK. Immediate and one-year 
results of percutaneous mitral balloon valvuloplasty using Inoue and double-balloon 
techniques. Am J Cardiol 1993;71:938-943. 
14. Abdullah M, Halim M, Rajendran V, Sawyer W, al Zaibag M. Comparison between 
single (Inoue) and double balloon mitral valvuloplasty: Immediate and short-term 
results. Am HeartJ 1992;123:1581-1588. 
15. Bassand JP, Schiele F, Bernard Y, Arguenot T, Payet M, Ba SA, Daspet JP, Maurat 
JP. The double balloon and Inoue techniques in percutaneous mitral valvuloplasty: 
Comparative results in series of 232 cases. J Am Coll Cardiol 1991; 18:982-989. 
16. Hung JS, Chern MS, Wu JJ, Fu M, Yeh KH, Wu YC, Cherng WJ, Chua S, Lee CB. 
Short and long-term results of catheter balloon percutaneous transvenous mitral 
commissurotomy. Am J Cardiol 1991;67:854-862. 
17. Ribeiro PA, al Zaibag M, Abdullah M. Pulmonary artery pressure and pulmonary 
vascular resistance before and after mitral balloon valvotomy in 100 patients with 
severe mitral stenosis. Am Heart J 1993;125:1110-1114. 
1 s. Dev V, Shrivavasta S. Time course of changes in pulmonary vascular resistance and 
the mechanism of regression of pulmonary arterial hypertension after balloon mitral 
valvuloplasty. Am J Cardiol 1991;67:439-442. 
19. Rothlisberger C, Essop MR, Skudicky D, Skoularigis J, Wisenbaugh T, Sareli P. 
Results of percutaneous balloon mitral valvotomy in young adults. Am J Cardiol 
1993;72:73-77. 
20. The National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry 
Participants. Multicenter experience with balloon mitral commissurotomy: NHLBI 
Balloon Valvuloplasty Registry Report on immediate and 30-day follow-up results. 
78 
Circulation 1992; 85: 448-461. 
21. Tanabe Y, Suzuki M, Takahashi M, Oshima M, Yamazaki Y, Yamaguchi T, Igarashi 
Y, Tamura Y, Yamazoe M, Shibata A. Acute effect of percutaneous transvenous 
mitral commissurotomy on ventilatory and hemodynamic responses to exercise. 
Pathophysiological basis for early symptomatic improvement. Circulation 
1993;88: 1770-1778. 
22. Cohen DJ, Kuntz RE, Gordon SPF, Piana RN, Safian RD, McKay RG, Baim DS, 
Grossman W, Diver DJ. Predictors of long-term outcome after percutaneous balloon 
mitral valvuloplasty. N Engl J Med 1992;327: 1327-1325. 
23. Chen CR, Cheng TO, Chen JY, Zhou YL, Mei J, Ma TZ. Long-term results of 
percutaneous mitral valvuloplasty with the Inoue balloon catheter. Am J Cardiol 
1992;70: 1445-1448. 
24. Pan M, Medina A, de Lezo JS, Hernandez E, Romero M, Pavlovic D, Melian F, 
Franco M, Cabrera JA, Romo E, Ortega JR. Factors determining late success after 
mitral balloon valvotomy. Am J Cardiol 1993;71:1181-1185. 
25. Palacios IF, Block PC. Acquired mitral stenosis: double balloon catheter technique. 
In: Cheng TO, ed. Percutaneous balloon valvuloplasty. New York: lgaku-Shoin, 
1992:221-236. 
26. Palacios IF, Block PG, Wilkins GT, Weyman AE. Follow-up of patients undergoing 
percutaneous mitral balloon valvotomy. Analysis of factors determining restenosis. 
Circulation 1989;79:573-579. 
27. Block PC, Palacios IF, Bloch E, Tuzcu EM, Griffen B. Late (two-year) follow-up 
after percutaneous balloon mitral valvuloplasty. Am J Cardiol 1992;69:537-541. 
28. Ribeiro PA, Fawzy ME, Mimish L, Awad M, Dunn BE, Arafah MR, Duran CGM. 
Mitral restenosis and mitral regurgitation 1 year after Inoue mitral balloon valvotomy 
in a population of patients with pliable mitral valve stenosis. Am Heart J 
1993; 126: 136-140. 
29. Hernandez R, Macaya C, Banuelos C, Alfonso F, Goicolea J, Inquez A, Fernandez-
Ortiz A, Castillo J, Aragoncillo P, Aguado MG, Zarco P. Predictors, mechanisms and 
outcome of severe mitral regurgitation complicating percutaneous mitral valvotomy 
with the Inoue balloon. Am J Cardiol 1992;70: 1169-1174. 
30. Inoue K, Hung JS. Percutaneous transvenous mitral commissurotomy (PTMC): The 
Far East experience. In: Topol EJ, ed. Textbook of interventional cardiology. 
Philadelphia: WB Saunders, 1990:887-899. 
31. Fatkin D, Roy P, Morgan JJ, Fenely MP. Percutaneous balloon mitral valvotomy with 
the Inoue single-balloon catheter: commissural morphology as a determinant of 
outcome. J Am Coll Cardiol 1993 ;21: 390-397. 
79 
32. Davidson CJ, Bashore TM, Mickel M, Davis K. Balloon mitral commissurotomy after 
previous surgical commissurotomy. Circulation 1992;86:91-99. 
33. Patel JJ, Mitha AS, Hassen F, Patel N, Naidu R, Chetty S, Pillay R. Percutaneous 
balloon mitral valvotomy in pregnant patien~s with tight mitral stenosis. Am Heart J 
1993; 125: 1106-1109. 
34. Kirklin JW. Percutaneous balloon versus surgical closed commissurotomy for mitral 
stenosis. Circulation 1991 ;83: 1450-1451. 
35. Patel JJ, Shama D, Mitha AS, Blyth D, Hassen F, le Roux BT, Chetty S. Balloon 
valvuloplasty versus closed commissurotomy for pliable mitral stenosis: a prospective 
haemodynamic study. J Am Coll Cardiol 1991;18:1318-1322. 
36. Turi ZG, Reyes VP, Raju S, Raju R, Kumar DN, Rajagopal P, Sathyanarayana PV, 
Rao DP, Srinath K, Peters P, Connors B, Fromm B, Farkas P, Wynne J. 
Percutaneous balloon versus surgical closed commissurotomy for mitral stenosis. A 
prospective, randomized trial. Circulation 1991; 83: 1179-1185. 
37. Turi ZG, Raju BS, Raju R, Reyes V, Fromm B, Singh S, Farkas P, Stephenson LW, 
Wynne J. Percutaneous balloon vs open surgical mitral commissurotomy: Three year 
follow-up of a randomised trial. Circulation 1993;88:1-339. 
38. Arora R, · Nair M, Kalra GS, Nigam M, Khalilullah M. Immediate and long-term 
results of balloon and surgical closed mitral valvotomy: A randomized comparative 
study. Am Heart J 1993;125:1091-1094. 
39. Farhat MB, Ayari M, Betbout F, Maatouk F, Gamra H, Jarrar M, Esseghairi K, 
Cherif A. Percutaneous balloon versus surgical closed and open mitral 
commissurotomy. J Am Coll Cardiol 1993;21 :428A. 
40. Braunwald E. Valvular heart disease. In: Braunwald E, ed. Heart disease. A textbook 
of cardiovascular medicine. 4th ed. Philadelphia: WB Saunders, 1992:1007-1077. 
80 
CHAPTER 8 
THE RESULTS OF PERCUTANEOUS BALLOON VALVULOPLASTY AT GROOTE 
SCHUUR HOSPITAL 
SECTION A: METHODS, DEFINITIONS AND PROCEDURES 
1) Methods 
By retrospective review of cardiac clinic records, hospital folders, echocardiography reports 
and catheterisation reports, data relating to the clinical, echocardiographic and haemodynamic 
variables relating to each valvuloplasty procedure were extracted. Procedures performed from 
the 18th March 1988 (when balloon mitral valvuloplasty was first performed at Groote Schuur 
Hospital) until the end of November 1992, form the basis for the study. 
Data were entered onto a commercially available database program (Paradox 3, Borland 
International). Statistical analyses were performed using Epistat Version 3.2 and Epi Info 
Version 5 software on an IBM compatible personal computer. 
Clinical data utilised are the opinions of one of four consultant cardiologists involved in 
patient care during the period under review. Echocardiographic data utilised are the opinions 
of one of two consultant cardiologists. Echocardiographic images were not available for 
review. The commonly used echocardiographic scoring developed in Boston appears to have 
been used from August 1989 at Groote Schuur hospital. 1 
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Haemodynamic data are those as listed in the printed catheterisation report for each 
procedure. These data were cross-checked with the haemodynamic data reported at the time 
of the joint departmental catheterisation review meeting held one to three days following the 
procedure. Recordings of haemodynamic data were checked only when data were incomplete 
or inconsistent. 
Follow-up clinical data were obtained from the clinical records. 
Procedures are assigned to a specific balloon type if reference is made to that type on the 
record sheet or in the clinical notes. 
Assignment to a specific New York Heart Association Class is inferred from symptoms listed 
in the clinical record, unless the attending clinician has allocated the patient to a specific 
class. 
Early mortality is defined as death during the first 30 days post valvuloplasty. 
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2) Statistical methods 
Standard descriptive statistics are used to describe groups. Chi-square and Fisher's exact test 
are used for discrete variables where appropriate. The signed rank test was used to evaluate 
paired non-parametric continuous variables. T-tests were used to evaluate independent 
samples. (Data sets generally had sample sizes greater than 30, allowing the use of parametric 
statistical testing in samples with potentially non-parametric distributions). 
3) Additional definitions 
Yalvuloplasty procedures were considered 'attempted' if balloon valvuloplasty was the stated 
aim of the catheterisation procedure as described in the clinical notes, prior to the procedure. 
Valvuloplasty procedures were considered to have been 'completed' if at least one balloon 
inflation across the mitral valve occurred. 
Yalvuloplasty procedures are considered 'successful' if no significant complication 
(tamponade, death or torrential mitral regurgitation) occurred following balloon inflation. 
'Technical success' refers to an increase in mitral valve area (as measured at catheterisation) 
of 50% with respect to original valve area, without the creation of more than 2 + mitral 
regurgitation. Data referring to an alternate definition of success, that is an increase in valve 
area to 1,5cm2 or greater, will also be provided. 
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4) Attempted valvuloplasty procedures 
Table 1 lists the number of procedures performed per year. An average of 2.2 attempted 
procedures were made per month over a 57 month period. 
Table 1 
YEAR No. of Attempts 
1988 18 
1989 15 
1990 33 
1991 30 
1992 28 
124 procedures were attempted. Six patients had two attempts at balloon valvuloplasty. Four 
of these patients had a second procedure after the occurrence of a significant complication 
(usually tamponade) during the first procedure. Two patients had a second balloon 
valvuloplasty during the 57 month period. 
Four procedures were not completed (see earlier definition). Two procedures were abandoned 
after minor tamponade during transseptal puncture . The procedures were then performed 
after a period of monitoring in the intensive care unit. During one procedure, the operators 
were unable to maintain the guidewire position in the left atrium and thus could not pass a 
balloon into the left atrium (attempted Bifoil catheter placement). During another procedure, 
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the balloon was inflated by error across the tricuspid valve when it was not recognised that 
the guidewire had slipped into the right atrium (attempted Inoue balloon placement). This 
procedure was repeated successfully at a later date. 
Unsuccessful procedures occurred in nine of 124 attempts (7 % ) . In some of these patients, 
symptoms may have been relieved after correction of an adverse event, but this adverse event 
precluded the accurate calculation of the post valvuloplasty valve area. In others the adverse 
event was either life threatening or its effect negated any improvement in effort tolerance. 
54 procedures were attempted with Bifoil or Trifoil balloons. 70 attempts were made using 
the Inoue balloon system. 
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SECTION B: BASE - LINE CHARACTERISTICS 
1) Base-line Characteristics 
The base-line data of the 118 patients who underwent 124 attempted procedures are listed 
below (Table 2). 
Table 2 Baseline data. ( modified after Cohen et al2) 
Age (mean) 30.7 (SD 10.2) 
Age (median) 30 
Males 19 (17%) 
Females 99 (83%) 
Rhythm - Atrial Fibrillation 9 (8%) 
Sinus 109 (92%) 
Previous surgical commissurotomy -
Open 2 (2%) 
Closed 12 (10%) 
Associated cardiac disease - clinical 
Aortic regurgitation 17 (14%) 
Aortic stenosis/ Aortic regurgitation 3 (2.5 % ) 
Tricuspid valve disease 1 (1 %) 
Pregnancy 8 ( 8 % of 
females) 
NYHA class 
II 24 (20%) 
III 79 (66%) 
IV 15 (13%) 
Additional pathology 
Previous CV A 2 
SLE 1 
Epilepsy 3 
Diabetes 1 
Th yrotoxicosis 1 
TB 1 
Recent caesarian section 1 
Recent pulmonary embolus 1 
Mental retardation 1 
Fibroid uterus 1 
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2) Haemodynamic data prior to valvuloplasty 
Table 3 documents prevalvuloplasty haemodynamic data as measured at catheterisation. Data 
were available for 122 patients. (Two procedures were repeated the day after the first 
attempt). 
Table 3 Data obtained at catheterisation 
Mitra! valve area 
(n = 122) 
Mean transmitral gradient 
(n = 122) 
Mean cardiac output 
(n = 122) 
Mean Left atrial pressure 
(n = 122) 
Mean pulmonary pressure 
(n = 121) 
0.9 (0.2) 
range 0.3 - 1.9 
median 0.9cm2 
16.9 (6.6) mmHg 
4.1 (1.1) 1/min 
25.9 (7.1) mmHg 
44.4 (17.1) mmHg 
Note: Cardiac output data are the average of the thermodilution and Fick principle outputs. 
Figures within brackets represent one standard deviation. 
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3) Echocardiographic data prior to valvuloplasty 
Data relating to valve areas measured prior to the procedure were available in 112 patients. 
The mean valve area was 0.86(SD 0.24)cm2 • These areas were usually derived from the half-
time pressure measurements. The means of the echocardiographically derived data are not 
significantly different from the data obtained at catheterisation, although data comparing the 
agreement between the techniques suggests that the measurements obtained in an individual 
patient may vary widely3 (Figure 1). 
Figure 1 Comparison of methods of measuring mitral valve area 
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Data reflecting echocardiographic score and the individual components thereof were available 
in 80 patients and are listed below (Table 4). The scores ranged form 3 to 9. The median 
score was 5. 
Table 4 Echo score data (median values) 
Mobility 1 
Thickening 2 
Calcification 0 
Subvalvar disease 2 
Total 5 
Two subjective variables, good and suboptimal, have been assigned retrospectively to the 
conclusion reported as regards the 'suitability' of the mitral valve on echocardiography. 106 
of 120 procedures were attempted in patients with 'good' valves (implying mobile, uncalcified 
valves). Twelve procedures were in patients with suboptimal valves. In two patients data 
relating to the echocardiographic appearance of the valves are not available. 
In 22 patients tricuspid regurgitation was detected at echocardiography. This was generally 
classified as 'mild'. 19 patients had mild aortic regurgitation detected at echocardiography. 
In two patients the aortic regurgitation was moderate in degree. Three patients had mixed 
aortic valve disease. Four patients had 2 + mitral regurgitation (as determined by mapping 
with pulse width doppler or colour flow doppler) and 42 patients had 1 + mitral regurgitation. 
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SECTION C: THE OUTCOME OF BALLOON VALVULOPLASTY 
1) The haemodynamic effects of balloon valvuloplasty 
Table 5 below lists the effects of balloon valvuloplasty on selected haemodynamic variables. 
Apart from cardiac output data, significant statistical differences exist in the pre- and post-
valvuloplasty populations. No attempt was made to compensate for any effect in change in 
cardiac output as a result of the creation of an atrial septal defect. 
Table 5 The haemodynamic effects of balloon valvuloplasty 
Pre-procedure Post procedure P value 
Mitral valve 
area 0.9(0.3) 2.0(0.6) p<0,000001 
Mean transmitral 
gradient 16.9(6.6) 5.3(2.6) p<0,000001 
Mean Left atrial 
pressure 25.9(7.1) 13.8(5.3) p<0,000001 
Mean Pulmonary 
pressure 44.4(17.1) 31. 7(13.0) p<0,000001 
Cardiac 
output 4.1(1.1) 4.5(1.1) p = NS 
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Of 120 procedures in which at least 1 inflation of the balloon across the mitral valve was 
achieved, 91 procedures resulted in the achievement of a mitral valve area of 1.5cm2 or 
greater, without additional mitral regurgitation of more than 3 grades (76%). 79% of 
procedures (95) resulted in an increase in the valve area of 50% or more. In 102 procedures 
(85 % ) the final valve area had increased to 1.5cm2 or greater or increased by 50% relative 
to its starting value or both. 
Left to right shunting across an atrial septal defect was sought during the early Groote Schuur 
experience. Published evidence as to the minor importance of the iatrogenic atrial septal 
defect has resulted in these shunts not being sought during later procedures. 
2) Echocardiographic assessment of the increase in valve area 
The mitral valve area was measured echocardiographically in 46 patients. The measurement 
was made between 1 to 3 days after the procedure. The mean mitral valve area increased to 
l .6cm2(SD 0.42). this measurement is significantly different from the pre-valvuloplasty 
measurement. Comparison of these values to the haemodynamically calculated values would 
be futile since only half of the patients underwent post procedure echocardiography. 
91 
3) Mitral regurgitation following balloon valvuloplasty: 
Angiographic assessment of mitral regurgitation was performed before and after each 
procedure, unless a significant complication had occurred. The grading of regurgitation used 
is the subjective 1 + to 4+ system, with 1 + being mild and 4+ being severe. The grades 
recorded are those as reported at the joint catheterisation review meetings. 
Table 6 below details the degree of angiographic mitral regurgitation. Mitra! regurgitation 
post valvuloplasty was only assessed in those patients who were haemodynamically stable. 
Table 6 
Mitra! regurgitation Pre-valvuloplasty Post valvuloplasty 
(Grade) (n = 120) n = 120 
0 86 (72%) 61 (51 %) 
1+ 30 (25%) 28 (23%) 
2+ 4 (3%) 18 (15%) 
3+ 8 (7%) 
4+ 3 (2%) 
Not measured 2 (2%) 
The degree of mitral regurgitation remained the same in 73 patients (61 %), worsened by one 
grade in 25 patients, two grades in 12 patients (10%), three grades in 5 patients (4%) and 
four grades in 1 patient (1 % ) . An improvement by one grade was noted in 6 patients (5 % ) . 
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4) Comparing the two techniques 
Table 7 details comparative data between the 2 types of balloon utilised at Groote Schuur 
hospital. 
Table 7 Comparison between the Inoue and Bifoil balloons 
INOUE BIFOIL 
Attempts 70 54 
Completed 67 53 
Successful 63(90%) 50(92%) NS 
Age 30.6(9.7) 30.5(10.6) NS 
MVA(pre) 0.98(0.27) 0.83(0.27) p=0.06 
MVA(post) 2.0(0.5) 2.1(0.6) NS 
LA/LV(pre) 16.0(6.0) 17.9(7.2) NS 
LAIL V (post) 5.6(2.7) 4.9(2.4) NS 
PA(pre) 42.1(16.2) 47.3(17.8) NS 
PA(post) 30.4(11.0) 33.9(15.8) NS 
MR(post) 3 8 NS 
Early MVR 2 1 NS 
Atrial 
perforation 3 0 NS 
Ventricular 
perforation 0 2 NS 
Deaths 0 2 NS 
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While the Inoue balloon group had a larger initial valve area, there are no differences 
between either group as regards success and significant complications. 
5) Outcomes in selected groups 
Eight pregnant patients with a mean age of 26 years underwent valvuloplasty. The outcome 
in five patients is known to have been successful. Mean duration of pregnancy was 27 weeks. 
(One additional patient was two months pregnant at the time of the procedure - unbeknown 
to the medical staff). Technical difficulties were experienced with manipulating the catheter 
in a 37 week pregnant patient - related to compression of the abdominal veins by the gravid 
uterus. Data relating to procedure duration are inadequately documented. 
The mean valve area (2. lcm2) achieved did not differ from the rest of the patients. One 
episode of false labour was documented. No other complications occurred in this group. 
Fourteen patients had undergone a previous surgical commissurotomy. Their mean age was 
33.6 years and mean valve area was 0.9(0.2)cm2 • This increased to 2.1(0.5)cm2 after 
valvuloplasty. Only one patient had a significant procedure related complication. 
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Table 8 below details the differences between those patients with a good outcome and those 
with a poor outcome (serious adverse events and/or increase in valve area of less than 50% ). 
Table 8 
Age 
Sex 
Echo score 
Previous 
surgery 
Left atrial 
pressure 
Pulmonary 
pressure 
Dilating 
balloon 
Good Outcome 
(n = 90) 
30.3(9.1) 
16 males 
5 
2 
25. 7(6.8) 
43.2(15) 
55 Inoue 
Bad Outcome 
(n = 32) 
32.0(12.5) 
5 males 
5 
5 
26.6(7.8) 
47.0(21.3) 
13 Inoue 
NS 
NS 
NS 
NS 
NS 
NS 
p = 0.046 
While the comparison between the two groups ignores variables which cannot be retrieved 
retrospectively (such as number of dilatations per procedure), it is of interest that a poor 
outcome is more frequently associated with the use of a Bifoil balloon. 
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SECTION D: THE COMPLICATIONS OF BALLOON VALVULOPLASTY 
1) Major Complications 
The complications of balloon mitral valvuloplasty are shown in Table 9. 
Table 9 Major Complications 
Death 2(1.6%) 
Severe Mitral Regurgitation 3(2.4%) 
Pericardia! Puncture 3(2.4%) 
Ventricular Perforation 2(1.6%) 
Hypotension post procedure 16(13 % ) 
Stroke 1(0.8 % ) 
Coronary embolus 2(1.6%) 
Pulmonary embolus 1(0.8%) 
Arterial embolus 1(0.8%) 
Transient ischaemic attack 1(0.8%) 
Deep vein thrombosis 3(2.4%) 
Bacterial endocarditis 1(0.8%) 
Late tamponade 1(0.8%) 
70 patients (56%) had uneventful procedures and were discharged without any complication 
occurring. 38 major complications occurred in 35 procedures (28 % ) . One patient had both 
a transient ischaemic attack and a deep vein thrombosis. One of the patients who was 
hypotensive post procedure also developed severe mitral regurgitation. The 'late' tamponade 
occurred in one of the patients who died. 
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Both deaths occurred several days following balloon valvuloplasty. A 32 year old female 
patient died three days following the procedure with unresolved pulmonary hypertension. The 
pathological features of established pulmonary hypertension were found at autopsy. A second 
patient aged 40 years died 14 days after the procedure during a pericardia! aspiration. The 
patient had presented with a Staphylococcus Aureus pneumonia. The patient needed ventilatory 
support. The diagnosis of mitral stenosis was made at this time. An uneventful valvuloplasty 
procedure was performed and the patient improved. Six days following valvuloplasty the 
patient developed the signs of a septicaemic illness, including disseminated intravascular 
coagulopathy. Staphyloccus Aureus was cultured from the bloodstream. The patient developed 
a pericardia! effusion and died during aspiration of a bloody exudate. Autopsy failed to reveal 
any evidence of iatrogenic cardiac injury. 
Three patients had severe mitral regurgitation following the procedure. Two patients required 
mitral valve replacement within the first week following the procedure and one patient 
underwent valve replacement six months after valvuloplasty. 
Two patients had left ventricular lacerations as a result of the tip of the Bifoil catheter 
straightening out with balloon inflation and tearing the ventricle. Both patients had uneventful 
surgical repairs of the ventricle. Both patients had echocardiographic documentation of an 
increase in mitral valve area. 
Three patients had cardiac chamber (atrial) perforation at the time of the transseptal puncture. 
Two were recognised immediately and the procedure was stopped after contrast was shown 
to be entering the pericardia! space. Both of these patients were observed in the intensive care 
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unit for twenty four hours and the procedure was then repeated. The third was not recognised 
until after valve dilatation had been performed and the patient became hypotensive, required 
emergency pericardia! aspiration. This laceration was repaired surgically. 
Two patients were noted to have ECG changes and moderate increases in cardiac enzymes 
following valvuloplasty procedures. One of these patients had a wall motion abnormality 
documented echocardiographically. Neither patient had chest pain. Both events were assumed 
to have been due to a coronary embolus at the time of procedure. Coronary angiography was 
not performed in these patients who did not experience any sequelae. 
A pulmonary embolus was assumed to be responsible for a persistent decrease in oxygen 
saturation data post procedure in one patient. 
An arterial embolus was diagnosed in a single patient who lost pedal pulses post procedure. 
The leg remained well perfused and embolectomy was not performed. 
Two cerebral events were noted. In a single patient a dense left hemiparesis was noted in the 
ward 12 hours post procedure. A right parietal infarct was demonstrated by computerised 
tomography of the brain. The other patient developed a transient weakness affecting the left 
hand two days following the procedure. 
One patient had a confirmed deep vein thrombosis diagnosed 14 days following the procedure. 
Deep vein thromboses were suspected (but not confirmed) in a further two patients who, 
following the procedure, developed a painful swollen leg. 
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Culture negative endocarditis was assumed to be responsible for the illness which resulted in 
the admission of a female patient one month after valvuloplasty. The original procedure had 
resulted in the creation of moderate mitral regurgitation which had not worsened the patient's 
symptoms. A large mass assumed to be a vegetation was seen in the patient's right ventricle. 
The illness had a 'septicaemic' character and was complicated by hypoxia and features 
compatible with septic pulmonary embolisation. The patient had severe tricuspid regurgitation. 
No organism was cultured. The patient improved and was submitted to mitral valve 
replacement and a tricuspid annuloplasty procedure. Large amounts of thrombus were found 
to be adhering to the tricuspid valve. Neither histological or bacteriological confirmation of 
endocarditis was obtained. 
Hypotension following valvuloplasty was noted in 16 patients. The patients responded to 
intravenous crystalloid administration, although up to four litres of fluid were sometimes 
required. The complication followed 13 procedures using the bifoil balloon and followed three 
using the Inoue balloon. Hypotension following valvuloplasty occurred more frequently in the 
first two years that the technique was used; 9 out of 16 events occurred in 1988 and 1989. 
The immediate cause of the hypotension was not always apparent but may have related to the 
combined results of opiate analgesia, overnight starvation and the continued use of diuretics 
on the evening prior to the procedure. In addition vagal responses to removal of groin sheaths 
may have contributed to the hypotension. More recently, diuretic therapy has been routinely 
discontinued prior to the procedure. A separate sheath is not used with the Inoue balloon. 
2) Minor Complications 
99 
Table 10 details the occurrence of minor complications. The difference between serious and 
minor complications is arbitrary and based on my perceptions of the time needed for the 
medical staff to 'sort out' the problem and its potential ability to cause death or severe 
morbidity. 
Table 10 Minor complications 
Complication Occurrence 
Vagal event 1 (1.6%) 
Seizure 1 (1.6%) 
Atrial arrhythmias 5 (4.0%) 
Displaced guidewire 2 (3.2 %) 
Burst balloon 1 (1.6%) 
Vomiting 1 (1.6%) 
False labour 1 (1.6%) 
Air in left atrium 1 (1.6%) 
Minor bleeding 5 (4.0%) 
These complications did not have any sequelae. The displaced wires resulted in inflation 
across the tricuspid valve in one patient and an inability to cross the atrial septum again in 
another. A brief seizure in one patient followed the administration of protamine sulphate. 
The atrial arrhythmias consisted of one episode of atrial flutter, three episodes of atrial 
fibrillation and one 'supra ventricular tachycardia'. Except for this event, which occurred 
during the procedure and necessitated electrical cardioversion, the other episodes were noted 
following the procedure. Two of these arrhythmic events required cardioversion. 
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SECTION E: SYMPTOMATIC IMPROVEMENT AND FOLLOW-UP 
1) Symptomatic improvement following valvuloplasty 
The improvement in effort tolerance following valvuloplasty is difficult to assess 
retrospectively. I have considered the symptoms as expressed at the first follow up visit as 
a better indication of symptoms following the procedure than the symptoms noted on 
discharge. Information is available in 102 patients. This information is summarised in Table 
11. 
Table 11 Symptoms post-valvuloplasty 
Lost to follow up 16 (13.5%) 
Died 2 (1.6%) 
Class I 59 (50%) 
Class II 35 (30%) 
Class III 4 (3%) 
Class IV 2 (1.6%) 
Worsened by 2 grades 1 
Worsened by 1 grade 1 
Remained unchanged 12 
Improved by 1 grade 35 
Improved by 2 grades 42 
Improved by 3 grades 9 
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2) Survival following valvuloplasty 
The figure below depicts the survival probabilities of the patient population following 
valvuloplasty. The method of Kaplan and Meier is used. 4 Only 1 late death occurred during 
the follow-up period and occurred in a patient with repeated cerebrovascular accidents post 
valve replacement who died 52 months post valvuloplasty. She had undergone mitral valve 
replacement and tricuspid annuloplasty 6 months after balloon valvuloplasty as a result of 
mitral regurgitation. The second curve depicts survival without mitral valve replacement, 
cerebrovascular accident, bacterial endocarditis or death. 
Figure 2 Survival post valvuloplasty 
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The mean duration of follow-up was 16 months. (Range Oto 56.6 months, median follow-up 
10.7 months). Survival at 10.7 months was 97% (52 subjects at risk). Event free survival as 
defined above was 88 % at 10. 7 months. No data as to the incidence of echocardiographically 
determined restenosis are available. Two patients required a repeat balloon dilatation during 
the follow-up period ( 1. 6 % ) . 
Seven patients underwent prosthetic mitral valve replacement during the follow-up period. 
The most common indication was persistent symptoms secondary to mitral regurgitation. One 
patient underwent open mitral valvotomy after the initial balloon dilatation could not be 
performed as a result of the inability to maintain the position of the guide wire in the left 
atrium. 
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CHAPTER 9 
DISCUSSION 
The published South African experience with balloon mitral valvuloplasty is relatively small 
with just over 900 patients being reported in the literature. 1•2•3 The group at Groote Schuur 
hospital bears some resemblance to these patients in terms of demographic composition and 
pathology. 
Table 1 below compares the Groote Schuur Hospital experience with the 2 largest Southern 
African series. 
Table 1 
Age(years) 
Balloon 
Death 
Optimal result 
Groote Schuur 
n = 118 
30.7(10.2) 
I 70 B 54 
1.6% 
76% 
Baragwanath 
n = 235 
29(11) 
I 145 D 90 
0.8% 
84% 
Wentworth 
n = 530 
30.5(12.5) 
I 430 B 100 
0.4% 
83% 
Note: Figures in parentheses denote 1 standard deviation. I - Inoue balloon, D - Double 
(Mansfield) technique, B - Bifoil/Trefoil balloon. Optimal result - mitral valve area ~ 
1.5cm2 and < 2+ mitral regurgitation. 
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The Groote Schuur experience has involved younger patients than reported in the series 
originating in the first world. 4 Authors from India have reported a smaller series with a mean 
age of 19 years. 5 
Haemodynamic results 
The haemodynamic results of balloon valvuloplasty at Groote Schuur do not differ markedly 
from other local centres. 1 The increases in valve area and decreases in transmitral gradients 
and pulmonary pressure are also equivalent to the results achieved by other major 
international investigators. 6 
Despite being a 'mixed' series, the haemodynamic results achieved are equivalent for the 
Inoue and the Bifoil/Trefoil balloons. This concurs with the results of the Johannesburg 
Hospital group. 2 Although reported in a series of older patients, Shaw et al reported similar 
equivalent haemodynamic results with the 2 balloon types in the United Kingdom. 7 
Complications 
The incidence of 'major' complications (death, early valve replacement, thromboembolus and 
tamponade) in the Groote Schuur series is 8 % which is similar to local 1 and international 
experience8• 
The incidence of severe mitral regurgitation and the need for early mitral valve replacement 
(2.4 % ) is comparable to the published results of other investigators who report figures 
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ranging from 2.4% 9 to 3.8% 8 • Mitral regurgitation increasing by 2 grades or more occurred 
in 15 % of patients. This is similar to other patients from South Africa' and more than the 
10% reported in the single operator series of Hung. 6 
The incidence of death ( 1. 8 % ) is higher than the Baragwanath experience (0. 8 % ) 1 or the 
Wentworth experience (0.4% )3but the absolute numbers of deaths in all series are small. (The 
differences fail to reach statistical significance). The deaths occurred in two extremely ill 
patients. Interestingly the mortality reported for closed mitral valvotomy at Groote Schuur 
Hospital for the period 1965 to 1977 was 2. 97 % . 10 
Ventricular perforation has not been reported with the Inoue balloon. The 1.6% incidence 
reported in the Groote Schuur hospital series occurred while the Trefoil or Bifoil devices were 
being used. This is similar to the experience of Shaw et al in Britain.7 Ventricular perforation 
is also documented by authors using the Mansfield technique. 11 On the other hand, the 
occurrence of pericardia! tamponade secondary to the transseptal puncture is common to all 
'antegrade' procedures and the incidence in the Groote Schuur group (2.4%) is similar to the 
experience of other authors. 12 Only one of the three patients needed surgical repair of an atrial 
tear after emergency pericardia! aspiration. 
Embolic events (cerebral, coronary and arterial) occurred in 4.2 % of the series. This is 
higher than the incidence reported at Baragwanath hospital (1 % )1 and in the large experience 
of Hung (2.5%)6 • The absolute numbers of patients in whom these events occurred is small 
and differences in definition of events may account for these differences. Transoesophageal 
echocardiography was not used in the Groote Schuur hospital patients undergoing balloon 
106 
valvuloplasty. The incidence of embolic events at Baragwanath hospital was noted to drop 
after the introduction of routine transoesophageal echocardiography prior to valvuloplasty. 
(No embolic events were documented in the 140 patients who underwent transoesophageal 
echocardiography prior to valvuloplasty). 1 
The description of hypotension following valvuloplasty has not been reported in the literature. 
13% of the Groote Schuur patients were significantly hypotensive. The possible reasons for 
this complication have been discussed in the results section (Chapter 8). 
Technique 
The perception that the Inoue balloon is easier to use as well as the fear of ventricular 
perforation with the Bifoil devices, have resulted in the Inoue balloon being favoured at 
Groote Schuur hospital. For similar reasons the Inoue balloon is favoured by the 
Johannesburg Hospital group2 and the Wentworth group. 3 At Groote Schuur Hospital the use 
of the Bifoil catheter was statistically associated with a 'bad' outcome. 
Special Groups 
The good results of balloon valvuloplasty in pregnant patients at Groote Schuur are in keeping 
with those reported by Patel et al from Wentworth. 13 The efficacy of the procedure in patients 
who had undergone previous surgical commissurotomy is in keeping with the published 
literature. 14 
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Symptomatic Improvement 
92 % of the group were in NYHA class I or II on first follow up visit. These results are 
equivalent to other local1 and international experience. 6 84 % of patients described symptoms 
consistent with an improvement of at least one NYHA class. 
Although survival data are available in the Groote Schuur hospital series up to 56.6 months 
post procedure, the median follow-up interval is 10. 7 months. The 88 % event free survival 
reported is equivalent to the results reported by Vahanian et al. 8 Total survival at 10. ?months 
was 97 % . The survival data are similar to those reported by Hung. 6 
Conclusion 
The initial experience with balloon valvuloplasty at Groote Schuur confirms that the procedure 
can be learnt and applied with equivalent success to other centres. The position of balloon 
valvuloplasty as a replacement for closed mitral valvotomy is still to be established 
particularly in the developing world. Paradoxically while an expensive technique is being 
learnt, the 'time-out' for trainee surgeons may result in the training of surgeons who cannot 
reliably perform the closed procedure. 
With increasing costs and the reallocation of health resources the use of expensive technology 
will become harder to justify. An alternative to the expensive Inoue balloon (which should 
not be resterilized7) will be needed. Balloon devices such as the Bifoil type which are more 
difficult and potentially more dangerous to use cannot be considered as a replacement. 
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